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Cancer incidence is high for aging minority and underserved populations, yet research is 
limited about patient-provider communications with aging racial and ethnic minority 
populations. Achieving high-quality cancer care is crucial to reducing health disparities 
for this population. However, potential shortages in professional health personnel, the 
cost to treat cancer, a strained health care system, and large aging populations contribute 
to the problem. The purpose of this qualitative study was to understand the personal 
experiences of aging minorities during cancer treatment decision making when 
communicating with their cancer care providers. Purposive sampling methods used to 
recruit 10 minority women and men born between 1946 and 1964 who had experienced 
communicating with providers and making cancer treatment decisions. In-depth semi-
structured interviews and thematic analysis of qualitative data was conducted. Important 
findings were barriers related to miscommunication with providers, the need for more 
time with the cancer doctor, and mistrust of the medical profession. Participants 
perceived poor interpersonal communication with providers as causing a lack of 
understanding regarding their cancer treatment options, which affected their decision 
making regarding their treatment. Barriers to communication included long wait times at 
public or teaching health care systems for follow up cancer care services. The findings of 
this study could be useful to assist health care providers in improving communication 
with their cancer patients, reducing cancer health disparities, and increasing the quality of 
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Chapter 1: Introduction to the Study  
Introduction  
Treatment decision-making with cancer is critical to successful care, mainly 
through effective patient-provider communications where information that is provided to 
the patient’s satisfaction. It is essential that providers communicate information about the 
patients’ specific cancer diagnosis, expected outlook, options available to treat the 
disease, and potential side effects, in order to succeed in providing quality care 
(Sheppard, Adams, Lamdan, & Taylor, 2010). In the study I used a qualitative approach 
to investigate phenomena related to patient-provider communication with aging Baby 
Boomer minorities and investigated how communication influences clinical decision-
making. 
Public health practitioners and policymakers are important in promoting healthy 
aging (Centers for Disease Control and Prevention [CDC], 2013). Cancer is a public 
health matter (CDC, 2013); public health can meet the developing needs of an aging 
society (Holtzman & Anderson, 2012). The incidence of cancer projected to increase 
among racial and ethnic minorities in the coming years (Edwards et al., 2014; Rahib et 
al., 2014). Moreover, by 2030, one in every five Americans—about 72 million people—
will be over the age of 65. Statistics indicate the cumulative projected incidence of cancer 
will escalate by 45%, from 1.6 million to 2.3 million (Smith, Smith, Hurria, Hortobagyl, 
& Buckholz, 2009). The site-specific cancers that primarily affect older adults and 
minorities in 2030 will be breast, colorectal, lung, and prostate. Estimating projections for 




and changing demographics (Smith et al., 2009). Cancer rates for many sites are also 
expected to rise among minorities and older adults by 2030 (Tables 1 and 2), from 21% 
to 28% (Smith et al., 2009; Figure 1).  
Table 1  
Projected Cancer Patients by Age and Sex from 2010 Through 2030 
     Cancer Site 









No. % No. % No. % No. % 
          All         
    2010 1,599,000 —    967,000 — 761,000 —    838,000 — 
    2020 1,957,000 22 1,302,000 35 900,000 18 1,057,000 26 
    2030 2,318,000 45 1,618,000 67 1,049,000 38 1,269,000 51 
Table 2  
Projected Cancer Patients by Racial Ethnicity from 2010 Through 2030 
Source: Smith, Smith, Hurria, Hortobagyl, & Buckholz, 2009 
 


















 No.  % No.  % No.  %       No.  % No.  % No.  %   
         All                
    
2010 
 
1,268,000 — 165,000 — 41,000 — 6,000 — 12,000 — 107,000 — 
  
    
2020 
 
1,480,000 17 217,000 31 64,000 58 8,000 39 18,000 45 171,000 59 
  
    
2030 
 
1,658,000 31 272,000 64 94,000 132 10,000 76 24,000 101 260,000 142 
  





Figure 1. Cancer projections by race and origin in the United States by 2030.   
 
Despite the continued growth of aging populations in the United States, research 
shows limited information exploring aging minorities involved in their own cancer care 
(Sysmonds, Lord, Mitchell, & Raghaven, 2012). Improving quality outcomes could 
influence cancer health disparities as this racially and ethnically diverse population ages 
(Nathan, Marshall, Cooper, & Huang, 2016). The incidence of cancer for older minorities 
presents multiple challenges. For example, cancer and treatments can be affected by age, 




Barriers to cancer treatment in older minorities include poverty, access to transportation, 
illiteracy, mental health, disabilities, cultural influences, access to quality cancer care, 
and poor language communications (U.S. Health and Human Services, Office of Disease 
Prevention and Health Promotion, 2014).  
This qualitative phenomenological research directly observed cancer treatment 
decision-making experiences among minorities born between 1946 and 1964—post 
World War II individuals. Quality cancer treatment includes patients and families 
educating themselves about treatment decisions and selecting effective treatment options 
that could reduce the growth of cancer while maintaining the quality of life during the 
cancer treatment process (American Cancer Society [ACS], 2016; Institute of Medicine 
[IOM], 2013). Additionally, a disproportionate number of African American, Asian, 
Hispanic or Latino, and American Indian/Alaska Native persons are likely to suffer a 
greater disease burden. Understanding patient-provider communication, a review of the 
role and impact of culture and socioeconomic status on cancer health disparities is 
significant.  
Background of the Study Problem 
Cancer is a leading cause of death of all ethnicities among both men and women 
(CDC, 2015). Screening can prevent many types of cancer including breast, colon, 
cervix, lung, or prostate and early detection may mean less intrusive treatment and better 
patient outcomes. Individuals who smoke, have poor diets, engage in limited physical 
activity, have a family history of the disease, and are exposed to certain environmental 




million individuals were projected to be diagnosed with cancer in 2017 (ACS, 2016), and 
the incidence of cancer was highest for the aged, minorities, and underserved populations 
(CDC, 2011; O’Keefe, Meltzer, & Bethea, 2015). ACS data for 2016 found that 595,690 
people died from cancer that year (ACS, 2016). Approximately 86% of individuals over 
50 years old are at risk for cancer (ACS, 2016).  
The first wave of Baby Boomer Americans turned 65 in 2011, and 10,000 
Americans celebrate their 65th birthdays each day (Pew Research Center, 2010). 
Consequently, cancer cases anticipate growing among this specific population of older 
Americans (White et al., 2014; ACS, 2016). The last wave of the Baby Boomer 
population (those born in the 1960s) will be 65 in the year 2029. This increase in the 
aging population in the United States will have wide impact on public health, social 
services, and healthcare. It will be important to promote healthy aging (CDC, 2013).  
Addressing cancer health disparities among aging minorities is critical to the 
health objectives for the United States through the Healthy People 2020 program (U.S. 
Department of Health and Human Services, Office of Disease Prevention and Health 
Promotion, 2014). Overarching goals of Healthy People 2020 are to achieve high quality 
health care, eliminate health disparities, and advance the health of all groups in the 
United States (U.S. Department of Health and Human Services, Office of Disease 
Prevention and Health Promotion, 2014). Efforts to reduce cancer health disparities 
require effective patient-provider communication strategies (Smedley, Stith, & Nelson, 
2003). However, ineffective patient-provider communication strategies for cancer 




treatment and outcomes (Sheppard et al., 2011). Several benefits of effective patient-
provider communications strategies for cancer treatment are provision of information to 
help patient decision-making with cancer care and good communication to strengthen 
patients’ social support networks, reduce anxiety, deliver high-quality cancer care, and 
improve quality of life (Mead et al., 2013; Wilkins et al., 2012). Numerous studies 
confirm the importance of effective patient-provider communications for initial cancer 
treatments, which result in improved survival outcomes (Epstein & Street, 2007; Palmer 
et al., 2014).  
Although morbidity and mortality of cancer have decreased and technological 
advances in cancer treatment have increased, minority populations experience lower 
cancer survival outcomes (IOM, 2013; Zonderman, Ejiogu, Norbeck, & Evans, 2013). 
Medically underserved racial and ethnic groups often present with a greater cancer 
burden, resulting in late stage diagnosis and poor survival outcomes, as compared to 
Whites (Byrd et al., 2011; Thompson et al., 2013). Moreover, medical providers who 
may be limited in their efforts to communicate to aging ethnic minorities (Schwartz, 
Lowe, & Sinclair) compound poor cancer outcomes. These populations are often low 
socioeconomic status, un- or underinsured, with limited health care access and 
underrepresentation in clinical trials, all of which create delays in receipt of cancer 
treatments in minority populations (IOM, 2013). Aging African American, Asian, 
Hispanic or Latino, and American Indian/Alaska Native populations disproportionately 
suffer a greater cancer burden (National Cancer Institute [NCI], 2015). According to the 




expected to increase by 39% compared to 89% for older racial and ethnic minority 









Figure 2. Expected population growth 65 and over, ethnic minorities, and 2016-2030.  
Source: U.S. Census Bureau. (2017). Population Division, Annual Estimates of  
the Resident Population by Sex, Age, Race, and Hispanic Origin for the United States  
and States: April 1, 2010 to July 1, 2016.  
 
Problem Statement 
There is limited research concerning the impact of patient-provider 
communications and cancer treatment decision-making options among aging racial-ethnic 
minorities who may have multiple communications challenges. Provider understanding of 
diverse cultural norms along with low health literacy of patients may affect access to 
cancer care (Epstien & Street, 2007; Sheppard et al., 2010). Cancer treatment options 
include surgery, radiation therapy, chemotherapy, hormone therapy, and immune therapy, 
all of which depend upon the type and size of cancer and whether cancer has spread to 
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treatment options available, several things influence cancer treatment. First is the 
financial burden many families experience. Another is patients’ limited experience with 
healthcare systems, and a third is understanding cancer care and treatment information in 
decision-making. Furthermore, structural barriers that include inadequate health 
insurance, the complexity of the health care system, the treatment facility operating 
hours, wait times to receive treatment, and access to transportation (ACS, 2016) impact 
cancer treatment. Patient-provider communication also affects specific cancer treatment 
delivery (ACS, 2016). Lastly, the clinician can also contribute to poor patient-provider 
communication and poor prognosis due to lack of training and insensitivity to patients’ 
cultural backgrounds and the psychosocial, sexual, and emotional issues experienced by 
cancer patients (Epstein and Street, 2007).  
According to the IOM (2013), quality cancer care happens when patients and 
families are the center of information exchange so they can make informed cancer 
treatment decisions. Effective patient-centered communications in cancer include open 
communications between cancer patients and the clinical team using evidence-based 
research to: (a) inform everyone about treatment options, (b) share decision making to 
influence patient outcomes, and (c) more fully involve patients with their care (Gagliardi 
et al., 2014; IOM, 2013; Epstein & Street, 2007). Shared control versus a physician 
control partnership is interrelated to the cancer patient’s level of education, ethnicity, 
gender, and participation in the cancer encounter (U.S. Department of Health and Human 
Services, National Institutes of Health [NIH], 2015]). Poor healthcare literacy in older 




about chronic diseases (IOM, 2011). Inadequate healthcare literacy can also lead to high 
mortality due to poor health status (CDC, 2016). 
The incidence of cancer is highest for aging minority and underserved populations 
(CDC, 2013). Racial and ethnic minority patients have multiple barriers to cancer 
treatment including access to care, culture, language, and low health literacy 
understanding about cancer diagnosis (Ko, Zuniga, Peacher, Palomino, & Watson, 2016). 
Some studies suggest that culture, issues of trust, poor healthcare literacy, or limited 
understanding of cancer prevention and control information may affect communication 
inequities (Palmer et al., 2014).  
Studies have documented recommendations to improve cancer communications 
for racial and ethnic minorities require practitioners to be culturally competent and 
effectively deliver information for decision-making about cancer treatment (Surbon 2010; 
Moore & Spiegel, 2004). Several studies show persistent challenges and disparities in 
clinical and patient communication and decision-making for cancer treatment among 
ethnic minority groups (Ko, et al., 2016; Palmer et al., 2014). In a systematic review of 
medical communications with racial-ethnic minorities, Ko et al. (2016) identified gaps in 
the effectiveness of clinician-patient communication among racial ethnicities. Other 
studies showed that physicians provided more limited health information to ethnic 
minority patients than to non-Hispanic White patients (U.S. Agency for Healthcare 
Research and Quality [AHRQ], 2015). In similar study, researchers examined racial and 
ethnic disparities in patient-provider communication and follow-up cancer care among 




follow-up cancer care with providers on quality care ratings as compared to Whites 
(Palmer et al., 2014). In this research study, I explored an important gap in understanding 
what patient-provider communication characteristics influence health outcomes of cancer 
patients, particularly how they affect cancer treatment decision-making for aging racial 
and ethnic minorities. Understanding the impact of these influences on cancer is critical 
to providing high quality cancer care for racial ethnic populations and reducing health 
disparities (NCI, 2017; CDC, 2013).  
Purpose of the Study 
The purpose of the study was to understand the personal decision-making 
experiences of aging minorities during cancer treatment when communicating with their 
cancer care providers. While there are studies that examine the cancer treatment 
experiences of non-Hispanic White men and women, there is limited understanding of the 
experiences of Baby Boomer minorities undergoing cancer treatment and care. This study 
focused on cancer treatment decision-making and patient-provider communication from 
the perspectives of minorities born between 1946 and 1964. This population often has 
less access to quality cancer care and may have fewer options to participate in cancer care 
decision-making (ACS, 2014). Information that does not effectively address the needs of 
Baby Boomer minority patients is a major concern in cancer treatment for this 
population. Understanding how this population perceives their own cancer diagnosis and 





The research questions guided the in-depth interviews, which was the primary 
collection tool to identify cancer treatment decision-making processes based on patient-
provider communication of African American, Asian, Hispanic or Latino, and American 
Indian/Alaska Native patients. The following research questions informed the study:  
Research Question 1: Do inadequate time allowed for medical decision-making 
and lack of active listening and empathy by care providers prove to be barriers to 
patient-provider communication for Baby Boomer minorities? 
Research Question 2: What are facilitators for post-cancer treatment (e.g., access 
to quality care and supportive networks) that improve quality of life of Baby 
Boomer minority cancer survivors? What are the barriers to improved quality of 
life?  
Understanding the differences between barriers and facilitators in cancer treatment 
decision-making and the types of treatments received by Baby Boomer minorities could 
help identify appropriate interventions for improving patient-provider cancer 
communication and reduce cancer disparities among aging minorities.  
Conceptual Framework 
The conceptual framework for this research was the social-ecological model 
(SEM). Public health officials for interventions at various levels to influence specific 
cancer care behaviors have used the SEM. The SEM was created by Bronfenbrenner 
(1979) and expanded by McLeroy, Bilbeau, Steckler, and Glanz (1988) to further the 




behavioral health from an ecological perspective (Moore, Buchanan, Fairley, & Smith, 
2015). The SEM framework identifies factors that influence behavior at multiple levels of 
an intervention designed to implement or encourage change at individual, interpersonal, 
organizational, community, and policy levels (McLeroy et al., 1988). Thus, the SEM 
framework’s multiple levels of influence used to improve health systems for cancer 
patients and reduce health disparities of minority aging populations through public health 
policies and programs (Moore et al., 2015). For example, activities at the community 
level of the SEM can facilitate comprehensive cancer control coalitions implement 
activities to support cancer survivorship among aging minorities have access to quality 
cancer care.   
Nature of the Study 
This was a qualitative research study. A phenomenological study was the most 
appropriate methodology to examine the beliefs and influences that guide aging 
minorities’ experiences with cancer treatment decision-making and communicating with 
their providers. Phenomenological studies focus on lived experiences or events in 
people’s lives that can better understand their perspectives and how they see their world 
(Husserl, 1970). Timely and accurate communication better informs decision-making 
critical to helping cancer patients navigate the myriad challenges present in a healthcare 
system in order to receive effective cancer treatment. The aim of this study was to outline 
improvements in patient-provider communication and provide insights into health care 
system changes that could improve cancer treatment outcomes. For this study, 10 men 




and were asked about their cancer treatment experiences. The data collection method was 
semi-structured interviews and observation of the participants to understand cultural 
nuances. In this research, I sought to determine effective interventions designed to 
eliminate or reduce cancer health disparities for aging minorities and to increase their 
quality of care for improved health outcomes. 
Definitions of Terms 
I used the following terms in developing an understanding of cancer treatment 
decision-making among minorities born between 1946 and 1964:  
Cancer: A group of abnormal cells that divide into multiple cells and can invade 
healthy tissues (CDC, 2016).  
Cancer staging: The extent of the cancer, such as the size of a tumor and if the 
tumor has metastasized in the body (NCI, 2015). 
Cancer survivor: A person diagnosed with cancer and still living with the disease 
(CDC, 2016).  
Cancer treatment: Treatment for cancer patients. Cancer treatment plans include 
surgery, radiation therapy, and chemotherapy (CDC, 2016).  
Decision-making or shared decision-making: Collaborative activities that 
encourage health care professionals and patients to make medical decisions together as an 
approach to improving the provider-patient communication process (NCI, 2015).  
Health equity: The social and medical determinants of access to health care for 
individuals to attain positive health outcomes (Braveman et al., 2011; U.S. Health and 




Health disparities or inequalities: are adverse differences in health status among 
populations; unfair healthcare (justice) systematically linked among socially 
disadvantaged populations with poor health (Braveman et al., 2011; NCI, 2015; U.S. 
Health and Human Services, Office of Disease Prevention and Health Promotion, 2014). 
Patient-centered care: A type of care that promotes effective communication 
between patients and their families and clinicians and health systems, to engage patients 
as active participants in their care to improve health care outcomes and increase patient 
satisfaction. (Epstein and Street, 2012).  
Patient-provider communication:  Effective interpersonal communication 
between patients and health care providers to improve health outcomes and adherence to 
treatment recommendations (Epstein and Street, 2007; Sheldon, Haoung, Berry, 2011).  
Quality of life: A person’s overall sense of well-being and ability to complete a 
variety of activities following cancer treatment (NIH, 2016).  
Social determinants of health: A complex web of the physical environment, 
health services, and societal factors that shape the conditions in which individuals live 
that promote health and avoid health inequalities  (U.S. Health and Human Services, 
Office of Disease Prevention and Health Promotion, 2014; Stewart & Wild, 2016). 
Assumptions 
The assumptions of this study were that participants’ goals were quality, healthy 
cancer treatment outcomes as long-term cancer survivors. I explained the questions to the 
participants to help ensure accurate data collection, and the participants conveyed their 




questionnaire. I also assumed the participants had a previous cancer screening or waited 
until late stage after receiving a diagnosis of cancer. I assumed the participants’ interacted 
with their cancer providers’ communication style.  
Scope and Delimitations 
This study examined themes of experiences by Baby Boomer minorities and their 
perceptions of cancer care treatment for older adults. These themes included shared 
decision-making, communication with and trust of the cancer care provider, and the level 
of satisfaction with cancer treatment. I did not observe interaction with clinicians but 
discussed with participants’ their previous cancer treatment decision-making experiences. 
Aging is a risk factor for cancer, and this study focused on midlife minority men and 
women between 54 to 72 years old. The participants of this study have had limited access 
to cancer care were low SES aging minorities. The results of the study may not be 
generalizable to a larger population.   
Limitations to the Study 
This qualitative study was limited to a small sample size of Baby Boomer 
minorities living in Atlanta, Georgia. The study was limited to patients living with any 
form of cancer. Either persons living with cancer or those diagnosed with cancer at some 
point throughout their lifetimes. A potential bias was limited to the selection of 
participants who are only a sample of the population they represent. The results from this 
small sample size may not be generalizable. Measures were taken to ensure the accuracy 




Significance of the Study 
This study, conducted with aging Baby Boomer minorities from Atlanta, Georgia, 
contributes to the body of knowledge regarding patient-provider communication 
experiences and the subsequent influences of those communications on cancer treatment 
decision-making. The findings might prompt additional research to discover effective 
interventions to improve patient-provider communication and eliminate cancer health 
disparities for the targeted population. The implications of this knowledge are that it 
could have the potential to promote a positive social change through cancer care 
providers who assist aging minority cancer survivors to have a better quality of life while 
receiving cancer treatment. The cancer study can potentially replicate to other public 
health interventions to increase population-based cancer screening and control efforts.  
Implications for Social Change 
There are several implications for positive social change resulting from this 
research. Among them are informing public health organizations about cancer health 
disparities among aging racial and ethnic groups in the United States. While cancer 
mortality rates have decreased in general population studies, cancer incidence remains 
high among certain racial and ethnic minorities (Halpern, 2015; National Cancer Institute 
[NCI, 2015]; Ramirez, 2013). Positive social change implications of this study may be 
improvements in access to cancer treatment and better patient-provider communication; 
another may be to provide insights into health systems changes needed to improve cancer 
outcomes and reduce health disparities for racial and ethnic minorities. A final social 




individuals by improving the experiences of cancer survivors through public health 
programs and policies.  
Summary 
In conclusion, despite access to cancer screening and technological advances in 
cancer care and treatment, more progress is necessary to reduce new cancer cases and 
increase quality cancer care for aging racial and ethnic minorities. In this 
phenomenological study, I sought to identify patient experiences and the provider 
behavioral influences that affect patient-provider communication and contribute to cancer 
health disparities among Baby Boomer minorities. The study was an examination of this 
population’s beliefs, perceptions, and experiences when discussing provider 
communications about cancer diagnosis and treatment.  
In Chapter 2, I address relevant literature on cancer treatment decision-making 
that supports the need for the study. In Chapter 3 expanded, I address the methodology 
used for data collection and answer research questions. Chapter 4, presents research 
findings from the in-depth interviews of study participants, and in Chapter 5, I interpret 






Chapter 2: Literature Review 
Introduction  
In this study, I examined the relationship between patient-provider 
communications among minority Baby Boomer individuals’ cancer treatment decision-
making. A substantial number of studies identify the importance of patient and provider 
interactions for positive clinical outcomes; however, much of the current literature relates 
only to health disparities. The review for this study was limited to literature on aging and 
cancer health disparities faced by underserved aging minority populations regarding 
cancer treatment and patient outcomes.  
Literature searches identified related qualitative studies on cancer epidemiology, 
health disparities and health equity, differences in cancer incidence among Baby Boomer 
minorities, and patient-provider communication about cancer treatment in aging minority 
populations. My research inquiries sought peer-review literature, public health reviews, 
and books. The databases searched included MEDLINE and Psych Info. Keywords and 
phrases used for the search were cancer health disparities, inequalities, racism, gender, 
race, ethnicity, underserved, patient satisfaction, patient-provider communication, 
patient navigation, race concordance, and aging minorities. The articles selected for this 
review explored topics on cancer health disparities and research on aging minority 
populations. I analyzed the studies published between 2007 and 2017 in this review using 
a literature matrix to examine the research questions, methodologies, and research 






There have been few studies specifically on aging racial and ethnic minorities and 
their cancer care decision making. The SEM was the framework used to guide this study; 
it helped me explain the interrelationship between aging minorities and cancer providers 
and to articulate the importance of effective communication with multiple levels of 
influences on cancer prevention and control.  
The SEM primarily focuses on the individual and population levels that determine 
health behavior at intrapersonal, interpersonal, organizational, community, and public 
policy levels (Moore et al., 2015; Fielding, Teutsch, & Breslow, 2010; McLeroy et al., 
1988). These levels of the SEM describing health behavior are all interdependent 
(McLeroy et al., 1988): 
 The intrapersonal level or individual behavior refers to knowledge, attitudes, 
personal and demographic characteristics that influence health behavior 
(McLeroy et al., 1988). 
 The interpersonal level is social support systems of family, friends, co-
workers, and others persons that can influence health behavior (McLeroy et 
al., 1988). 
 The organizational level refers to institutions in organizational settings such as 
a school or workplace that plays a significant role in health behavior 




 The community level speaks to relationships among groups, institutions, 
organizational structures, and neighborhoods that impact access to care and 
influence health behavior (McLeroy et al., 1988).  
 The policy level concerns public policies from local, state, national 
governmental agencies that affect health behavior (McLeroy et al., 1988).  
In an earlier study, Earp, Altpeter, Mayne, Viadro, and O’Malley (1995) designed 
an intervention to direct minority, rural women 50 years and older to mammography 
screening in a five-county region of North Carolina. The researchers used various 
theoretical constructs of the social ecological model; PRECEDE model for health 
promotion, the Health Belief Model and the Stages of Change model for behavior change 
to increase breast cancer screening in older minority women. The social change 
implication was to reduce cancer mortality among racial ethnic populations. Studies have 
suggested that low-income African American are more likely to die of breast cancer as 
compared to White women (Hall & Johnson-Turbes, 2015).   
McNeill et al. (2009) developed an intervention based on the social ecological 
framework that examined health behavior through a randomized controlled trial to 
increase colorectal cancer screening among low-income racial and ethnic minority adults 
over 50 years of age in public housing units. The researchers examined social support and 
social networks in public housing residents and trained peer health advisors to increased 
rates for colorectal cancer screening among residents. The study examined 12 housing 
sites to determine if residents received a recommendation for colorectal cancer screening, 




The public health action model for cancer survivorship developed by Moore et al. 
(2015) was an integrated model of the SEM. This framework was significant in 
addressing the public health needs of cancer survivors through the National Action Plan 
for Cancer Survivorship (Moore et al., 2015). This integrated SEM model includes a 
collaboration of intrapersonal and interpersonal networks, community and organizational 
groups, and policies (Moore et al., 2015; Figure 3). 
 
Figure 3. Diagram of SEM an integrated framework. Source: Adopted from Moore et al., 
2015 
Health Disparities and Health Equity  
Health disparities defined by multiple entities and often used in the literature to 
describe inequality in utilization of health care services. An IOM (2013) report describes 
health disparities as "differences in access to available health care" (p. 29). In 2000, 
Congress passed Public Law 106-525 known as the Minority Health and Health 




NCI to establish the National Institute for Minority Health and Health Disparities to 
improve health lives of minorities (NCI, 2016). The NCI defines health disparities as 
follows: "A population is a health disparity population if there is a significant disparity in 
the overall rate of disease incidence, prevalence, morbidity, mortality or survival rates in 
the population as compared to the health status of the general population" (Minority 
Health and Health Disparities Research and Education Act of 2000, p. 2498).  
Several factors determine health disparities (CDC, 2013). One is socioeconomic 
status, which influences a person’s position in society. Socioeconomic status may be 
determined by income, educational attainment, occupation, health care access, and 
financial wealth (Saydah, Impertore, & Beckles, 2013; CDC, 2013). According to CDC’s 
Health Disparities and Inequalities Report, researchers concluded that higher education 
and incomes contribute to better access to health care (CDC, 2013). The same report 
found that having only a high school diploma along with living in poverty negatively 
affects health outcomes. The CDC report described disparities with multiple diseases, 
risk factors, environmental assessments, social determinants, and access to health care 
(CDC, 2013). Barriers to cancer treatment and accessing health care services are critical 
for underserved and geographically confined ethnic minority populations (NCI, 2015). 
Other factors that complicate poor cancer outcomes include higher levels of 
environmental carcinogens, risk factors such as cigarette smoking and poor diet, and lack 
of health education about health risks (CDC, 2013, IOM, 2013, NCI, 2015). Studies show 
that some people with low socioeconomic status are at a higher risk of disease due to 




socioeconomic status also have limited access to nutritious foods that may lower cancer 
risk (O'Keefe et al., 2015).   
In addition to socioeconomic status, other social determinants cause health 
disparities. These include where a person is born and raised, where they work, and their 
age; also, the delivery of health care (CDC, 2013). According to the World Health 
Organization (Stewart & Wild, 2016), "the social determinants of health are mostly 
responsible for health inequities—the unfair and avoidable differences in health status 
seen within and between countries" (p. 6). Additional social determinants of health 
include race and ethnicity, sex, sexual orientation, age, and disability (CDC, 2014). Data 
from CDC's Reaching Ethnic Approaches to Community Health obtained from 
surveillance of several U.S. communities showed racial and ethnic communities have a 
high burden of disease and limited access to health care services in comparison among 
the majority populations in the same area (CDC, 2014).  
Disparities of Cancer Incidence in Baby Boomers Minorities 
Many governmental and non-governmental agencies track cancer incidence of all 
populations and minority populations. Data from the ACS estimate that around 1,685,210 
new reports of cancer diagnosis projected in 2016 and 1,630 people will die each day 
from cancer in 2016 (ACS, 2016). The National Cancer Institute (NCI) Surveillance, 
Epidemiology, and End Results (SEER) project new cases reported as 448.7 per 100,000 
individuals annually (NCI, 2016). Mortality data show 168.5 per 100,000 individuals 
annually was based age-adjusted 2009-2013 cases and fatalities (NCI, 2015). In 2013, an 




(NCI, 2015) one out of every 25 Americans is a cancer survivor (ACS, 2014). The 
potential for cancer increases with advancing age (CDC, 2013); with 86 percent of 
cancers diagnosed are those individuals over 50 years old in the United States (ACS, 
2016).  
Although there continues to show notable gains overall health of Americans 
(Healthy People 2020), disparities in the morbidity and mortality specifically among 
African Americans, Hispanics, Native Americans, Alaska Natives, and Asian Pacific 
Islanders remains a serious health threat (CDC, 2015). The NCI defines cancer health 
disparities as “adverse differences in cancer incidence, prevalence, and mortality” (NCI, 
2015). Disparities also exist due to geography or region of the country. The elderly, 
disabled people, and uninsured populations in the study population often reside in rural 
places where shortages of medically qualified personnel. In addition, seniors in these 
rural areas—who live below the poverty line, must often travel long distances to seek 
medical care (CDC, 2015).  
There is also a continuing increase of minority populations with cancer in the 
United States (NCI, 2015). Data from the Administration on Aging (AoA) indicate aging 
adults of color have expanded an additional 3.2 million between 2003 to 9.5 million in 
2013 (AoA, 2013). The older population estimated growth is around 21.1 million in 2030 
(AoA, 2013). The aging white population is forecasted a 50 percent increase from 2013 
to 2030 for those individuals over 65 in comparison to 123 percent for aging adults of 
color (AoA, 2014). The changing demographics of racial and ethnic minorities aging 




The Baby Boomers Cohort 
According to U.S census data, the Baby Boomers cohort (U.S. Census Bureau, 
2014) has drastically altered populations. Therefore, it is important to understanding this 
group and it will shape the demographic composition of the United in the future. This 
birth cohort is responsible for the significant rise in birth rates between 1946 and 1964 
(U.S. Census, 2014). This generation has influenced many sectors such housing, 
recreation, business, healthcare, education, and government as they move into retirement 
and old age (AoA, 2013). The first year the Baby Boomers generations turned 65 was in 
2011. By 2029, this generation will make up over 20 percent among the U.S. population 
(AoA, 2013; U.S. Census, 2014). Within this cohort is more racially and ethnically 
diverse and is expected to grow into a majority population by 2043 (AoA, 2013; U.S. 
Census, 2014).  
Race and Ethnic Composition of Baby Boomers Minorities  
The composition of minorities represents a range of races and ethnicities where 
21.2 percent of those age 65 and over: 8.6 percent were African-Americans; 3.9 percent 
were Asian or Pacific Islander; 0.5 percent were Native American;; 0.1 percent were 
Native Hawaiian/Pacific Islander, and Hispanic represented 7.5 percent of the older 
population AoA, 2013; U.S. Census, 2014).  
Racial and ethnic minority populations have increased from 6.3 million in 2003 
(17.5 percent of the older adult population) to 9.5 million in 2013 (21.2 percent of older 




Population projections statistics show increase of 21.1 million racial and ethnic minorities 
in 2030 (28.5 percent of older adults) (AoA, 2013; U.S. Census, 2014). 
Demographic Changes for Cancer 
Disparities in cancer treatment and outcomes have become an increasing health 
challenge among ethnic minorities. The reasons for health disparities are complex, but 
demographic changes account for much of them. Many barriers to quality care include 
jobs, housing, level of education, and racial discrimination accounts for health disparities.  
Economic Burden of Cancer among Minorities Born between 1946 and 1964 
The aging of America indicates more individuals can receive a diagnosis of 
cancer. The increase in the overall population of aging minorities is likely to affect the 
burden of cancer care, especially since research shows specific minorities have higher 
prevalence cancers and lower survival rates than whites (ACS, 2015). The cost to 
treatment cancer in the United States is massive, and cost continue to increase due to 
individuals living longer as cancer survivors (Yabroff, Lund, Kepka, & Mariotto, 2011). 
Factors contribute to the cost of cancer and make the disease a burden include health care 
expenditures, productivity losses due to prolonged treatments, and out of pocket cost for 
cancer patients and their families. According to the Congressional Budget Office (GBO), 
national health care expenditures make up 18 percent of the Gross Domestic Product 
(GDP), but projected estimates will rise to 25 percent of GDP by 2037 (GBO, 2012). 
Moreover, direct medical costs associated with the burden of cancer include 




immunotherapies that measure by insurance payments or patient out-of-pocket cost 
(Yabroff et al., 2011).  
Cancer costs vary according to the phase and type of cancer diagnosed. In 2010, 
the net monthly cost for senior women with breast cancer was $1923 and $5,740 for lung 
cancer (Yabroff et al., 2011). The total cost of cancer in 2010 estimated around $124.5 
billion dollars. For example, higher cost is associated to treat female breast cancer at 
$16.5 billion, colorectal cancer at $14.1 billion, and prostate cancer at $11.9 billion 
(Yabroff et al., 2011). Future estimated cancer cost projected to reach $157.8 billion by 
2020 (Yabroff et al., 2011). However, estimates from the AHRQ estimate the direct cost 
to treatment of cancer in the United States (total of all health care expenditures) in 2013 
were $74.8 billion (AHRQ, 2014; NCI, 2015). Cost, as a barrier that generally prevents 
many from receiving access to quality cancer care, is also a barrier to Baby Boomers 
aging minorities receiving optimal healthcare. Finally, targeted therapies for new cancer 
treatments and technological advances in genetic mutations for improving treatment 
responses for specific diseases are expensive and increase the cost of cancer care (AHRQ, 
2014). Health disparities in cancer affect specific racial and ethnic minorities (CDC, 
2016; U.S. Office of Minority Health [OMH], 2015). Here are some examples: 
All cancers with lower life expectancy likely affect African Americans for men 
and women of any race or ethnicity group as compared to whites (NCI, 2015; OMH, 
2015). African American women are 40% have a greater risk of death from breast cancer; 
whereas many African American men do not survive past 5-years from lung, colon, and 




American Indian/Alaska Native populations have lowest rates of cancer as 
compared to whites. American Indian/Alaska Native men and women have high 
incidence of liver, gastrointestinal, and renal diseases and greater risk of death from these 
diseases (NCI, 2015; OMH, 2015). 
Asian Americans have lower incidence of cancer rates than the non-Hispanic 
white populations. Asian/Pacific Islander men and women have a higher mortality rate of 
stomach cancer (NCI, 2015; OMH, 2015). 
Native Hawaiians/Pacific Islanders have a high probability for receiving a 
diagnosis for cancer. American Samoan women have a high mortality of cervical cancer. 
American Samoan and Native Hawaiian men also have high rates of cancer (NCI, 2015; 
OMH 2015). Native Hawaiian men are highly likely to die from any form of cancer 
(OMH, 2015). In the U.S., territories of Guam and Micronesia populations have 
incidence of liver cancer, versus the majority population (NCI, 2015; OMH, 2015).  
Hispanic American men and women have lower cancer rates than the non-
Hispanic white population. For Hispanic men, the rate of prostate cancer is low. Hispanic 
women have lower incidence rates of breast cancer, but higher mortality of cervical 
cancer (OMH, 2015).  
Public Health Efforts to Win the War on Cancer 
Numerous studies have been published that document efforts by the United States 
to win the “war on cancer.” The United States President (NCI, 2016) announced a “War 
on Cancer” in 1971. Later that year, Congress amended the Public Health Service Act 




Cancer Institute (NCI) to strengthen the scope of funding for cancer treatment research 
(NCI, 2016; Frieden et al., 2008). However, funding for this massive initiative was 
limited to cancer prevention research.  
Secondary prevention efforts to reduce cancer mortality and help to achieve 
winnable battle against cancer through successful through screening and early detection 
initiatives. Several of these initiatives address breast and cervical cancer. Breast cancer 
leads as a cause of death for many women of all ethnicities (CDC, 2014c). Annually, 
many women are determined to have breast and cancer cancers and die from these 
diseases (CDC, 2014c). Screening mammograms and Pap test helps to find female 
cancers ahead of time when these diseases are most treatable to decrease mortality for 
these two cancers (CDC, 2014c).  
Other legislation enacted to aid to lower cases of cancer in the United States. In 
1990, Congress passed the Breast Cancer Mortality Prevention Act of 1990 (CDC, 
2016b). The law authorized the Centers for Disease Control and Prevention (CDC) to 
create the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) 
(CDC, 2016b). The CDC provides dollars to the 50 United States, the District of 
Columbia, five U.S. territories, and 11 American Indian/Alaska Native tribes or tribal 
organizations (CDC, 2016b). The NBCCEDP provides women with access to cancer 
screening and diagnostic services to ages 50-64 who are also low income and under-
insured or uninsured (CDC, 2016). NBCCEDP data shows from 1991 to 2015 that more 
than 4.9 million women were served, providing over 12 million breast and cervical 




cancers, and 175,688 premalignant cervical lesions, of which 40 percent were high-grade 
(CDC, 2016).  
Another public health effort aimed at winning the war on cancer focused on 
colorectal cancer. CDC’s Colorectal Cancer Control Program (CRCCP) provides funding 
to states and tribal organizations to screen men and women for colorectal cancer (CRC) 
through education and policy and systems change (CDC, 2013). CRC affects men and 
women. CRC is number two in causes of death in the United States (CDC, 2014). 
According to the U.S. Preventive Services Task Force (2016), a CRC recommended 
screening test could save lives through a high-sensitivity fecal occult blood test, 
sigmoidoscopy, and colonoscopy. These tests can locate cancer early before it moves to 
higher level of progression and treat the disease quicker.  
Cancer Treatment Disparities among Baby Boomer Minorities 
Addressing the challenges of aging minority populations to promote cancer 
treatment is critical for the future of cancer services (AHRQ, 2015). Some of the 
challenges in general are a shortage of oncology personnel, the soaring cost to treat 
cancer, and the changing demographics due to the number of aging Baby Boomer 
minorities diagnosed with cancer. Another challenge is delivering accessible affordable 
cancer care to aging minorities; assist them with shared treatment making decisions with 
their cancer care providers. According to Smith et al. (2009) argued that the number of 
cancer deaths would grow unless efforts to improve cancer treatment for underserved 




Historically, older adults and minorities have been under-represented in cancer 
clinical trials. Some barriers for clinical trials participation eligibility include 
comorbidities of the patient, transportation to the study site, other financial obstacles, the 
drug not paid by Medicare as an investigational treatment (Smith et al., 2009). Data from 
the U.S. Food and Drug Administration (FDA), there are biological differences and 
genetic variations in clinical trial participation (FDA, 2016). Some drugs can be more 
toxic in one ethnic group than they would be in another; contraindications to other drugs 
such as antidepressants and blood-pressure medications means they might be less 
effective in one group than in another. However, clinical trials are the only method to 
determine disparities in efficacy by racial and ethnic group (FDA 2016). Lack of minority 
participation in clinical trials may also be due to a lack of trust. The Tuskegee Syphilis 
Study conducted between 1932 and 1972 where the U.S. Public Health Service, is an 
example where scientists recruited poor black sharecroppers in Alabama to study syphilis 
(CDC, 2015). However, the investigators continued the study long after penicillin 
discovery to treat syphilis (CDC, 2015; FDA, 2016). As a result, safeguards for clinical 
trials participants among minorities and other population require institutional review 
boards of scientists, physicians, and lay individuals to ensure safety and effectiveness in 
drugs and protect rights of human subjects in research (FDA, 2016). 
Patient-Provider Communication and Cancer Treatment 
Efforts to eliminate cancer health disparities require effective patient-provider 
communication strategies (AHRQ, 2015). Information that does not effectively address 




this population. First, the healthcare professional workforce is under-represented among 
racial and ethnic minorities that increases access to care (OMH, 2011). Race-concordant 
relationships where health professionals treat patients different are often barriers to 
effective communication (Schoenthaler et al., 2012). Therefore, policy efforts to increase 
workforce diversity in clinical practice needs better patient-provider communication with 
aging minorities. The lack of effective patient-provider communication strategies for 
cancer treatment of minority and underserved populations may result in poor cancer care 
outcomes (Sheppard et al., 2010). One benefit of effective patient-provider 
communications in cancer treatment means patients make better informed decisions about 
their cancer care and treatment; another benefit of improved communication is social 
support networks are strengthened; anxiety is reduced, higher-quality cancer care is 
delivered, resulting in an improved quality of life (Mead et al. 2013).  
Communication styles and the quality of care affect the health outcomes (Bylund, 
Peterson, & Cameron, 2012; Quillin et al., 2009). Few studies have focused specifically 
on minorities born between 1946 and 1964 on patient and provider communication 
influences the health outcomes of cancer survivors and their treatment decision making.  
Patient-provider communication is a critical ingredient to the quality of life 
affecting health care quality before and after cancer treatment and increase cancer 
survivors in the United States (Epstein & Street, 2007). In earlier studies by Ong and 
colleagues, (1995) doctor-patient communication includes several components such as 
fostering a good interpersonal relationship, exchanging information to healing, and 




information can increase cancer survivorship associated with cancer care (Arora, Reeve, 
Hays, Clauser, & Girvan, 2011; Song, et al., 2013). 
Effective patient-provider communication happens when the patient assumes an 
active role in their cancer care. Hibbard and colleagues (2013) concluded that patients 
who are actively engaged in their care are confident in communicating with providers, 
making, and maintaining decisions that are important to their long-term cancer survival. 
Studies on long-term cancer survivors among racial ethnic populations reveal poor 
communication, and lower self-efficacy in making medical decisions, and more inferior 
quality of care on their follow-up patient cancer care as compared to whites Palmer et al. 
(2014). Researchers also suggest providers should periodically provide communication 
follow-up to encourage racial ethnic minority patients engaged about their cancer care 
(Palmer et al., 2014). Consequently, providers should increase their knowledge of 
cultural competence training for cancer care working with racial ethnic minorities 
(Palmer et al., 2014).  
Arora’s (2003) findings on provider communication indicate individual behavior 
has a great impact on the patient’s health outcomes, as patients are already devastating of 
having received a diagnosis of cancer. However, studies on provider perceptions of 
patient-provider communication identify a breakdown in cancer care communication at 
multiple levels including patient, provider, and health system level and suggest 
integrating multi-level perspectives is essential to delivering patient-centered cancer care 
(Prouty et al., 2014). Reyna, Nelson, & Han (2015) discuss more evidence-based 




decision making in cancer where the patient understands all the facets of the cancer 
experience.  
Cancer Survivor Studies 
In a study understanding the importance of quality follow-up cancer care, Arora et 
al. (2011) at the NCI developed the Assessment of Patients’ Experience of Cancer Care 
(APECC) study, a population-based study of cancer survivors’ experiences of receiving 
follow-up care. The primary goals of the APECC study were to develop and pilot test a 
survey instrument that would assess cancer survivors’ perceptions quality of their cancer 
care. The study also identified socioeconomic, clinical, and patient-level factors to rate 
their quality of care, and evaluate the relationship between the survivors’ assessment with 
the overall ratings (Arora et al., 2011). A pilot study to test the effectiveness of the 
APECC survey conducted by NCI researchers and in collaboration with the Northern 
California Cancer Registry, a partner of NCI’s Surveillance, Epidemiology, and End 
Results (SEER) program. The study design included the recruitment of eligible cancer 
survivors diagnosed with leukemia, bladder, or colorectal cancer 2-5 years before 
enrolling in the APECC study, and be at least 20 years of age. Cancer survivors must 
have received follow-up care within the last 12 months, and respond to cancer survivors’ 
experiences listed on the survey. A cross sectional mailed APECC survey and 
information letter describing the study sent to 1,572 were eligible cancer survivors to 
participate in the study, 774 or 49% responded or returned the questionnaire. The study 
sample consisted of 623 cancer patients, or 81% of respondents indicated they had 




participants had colorectal cancer; 14% had leukemia, and 28% had bladder cancer, all 
received cancer treatment in the past year; and 50% had multiple comorbidities (Arora, et 
al., 2011).  
The APECC survey included 33 areas to assess survivors' perceptions of the 
quality of their follow-up care in the last 12 months. The results of researchers suggest 
that underserved populations may be at risk of experiencing poor outcomes, and a better 
continuity of care may lead to good patient experiences (Arora, et al., 2011). The 
researchers concluded that physician knowledge of cancer patients is a key quality 
indicator; improving patient-centered cancer care may improve patient’s experience 
through communication and better coordination of care (Arora, et al., 2011). A limitation 
of the study is not able to compare follow up care experiences some racial ethnic 
minorities’ subgroups due to low sample size. 
In another study, Palmer et al. (2014) examined racial and ethnic disparities in 
patient-provider communication among cancer survivors using the survey data from the 
Follow-Up Care Use among Survivors (FOCUS) study, a population-based study of 
eligible cancer survivors conducted between March 2005 and 2006. The sample size of 
1196 cancer survivors that were randomly selected from the Los Angeles and Northern 
California Surveillance SEER registries. The eligible cancer survivors diagnosed with 
colorectal, prostate, endometrial, or ovarian cancer, age 21 at diagnosis, males and 
females among non-Hispanic white, African America, Hispanic and Asian completed the 
survey on physician use for cancer related follow up care. The results indicate that 




ratings and health outcomes as compared to Whites (Palmer et al., 2014). The researchers 
concluded that more research to address racial ethnic disparities in cancer survivors to 
improve patient experiences and quality of life outcomes (Palmer et al., 2014). 
Patient-Centered Care  
The IOM reported in their Crossing the Quality Chasm and recommended 
improvements in “health care delivery that should be patient-centered, meaning care 
should be responsive to individual patient preferences, needs, and perspectives and 
ensure that patient values guide clinical decisions” (IOM, 2001). The National Cancer 
Institute (NCI) created a conceptual framework for understanding patient-centered care 
for patient-provider cancer communication and developed an evidence-based monograph, 
Patient Centered Care Communication in Cancer Care, (Epstein and Street, 2007) 
working with multiple experts in oncology, primary care, and patient advocates (Arora, 
Street, Epstein, & Butow, 2009). The monograph describes the interaction of patients, 
families, clinicians, health care organizations understand cancer communication research 






Figure 4. Model of patient-centered care. Source: Epstein, R.M., Street, And R.L. Jr. 
Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing 
Suffering. National Cancer Institute, NIH Publication No. 07-6225. Bethesda, MD, 2007. 
 
Shared Decision Making  
Shared decision-making is effective when patients know about cancer treatment 
options, risks, benefits, and their values and preferences considered into treatment 
decision-making (Katz, Belkora, & Elwyn, 2014). For many patients with cancer, 
discussions can be complicated about specific options for treatment and continuing 
cancer care. Several studies continue to plague disparities among certain racial groups on 
treatment choice and their attitudes in communication with providers regarding cancer 
treatment decision making (DeSantis and Naishadham, 2013; Haider, Scott, Rehman, et 
al., 2013). In many cases, minority patients experience less satisfaction of care including 
trusting the clinicians in communication about their cancer care (Thomas, Goff, Tsang, et 




According to Luo, Spolverto, Johnston, Haider, and Pawlik (2015) shared 
decision-making studies account for several factors that determine cancer treatment 
choice for racial ethnic minorities including not treating the cancer or best supportive 
care, non-surgical treatments such as chemotherapy, radiation therapy, or surgery. Patient 
and provider communication is critical in what choice of therapy the patient chooses for 
minority patients. Differences in cancer treatment vary across different minority groups, 
and patient-physician communication, decisional control preferences, and cultural 
attitudes contribute to cancer options for minority patients (Luo et al., 2015). The 
researchers argue that while the physician is the initial person of information patients rely 
on, physicians may act poorly in providing accurate and timely information to minority 
patients making them limited informed about specific treatment options for their 
treatment satisfaction (Luo et al., 2015). The final cancer treatment decision lies with the 
patient and the family when they are engaged in their decision (Luo et al., 2015). The 
quality of patient-provider communication and decision-making can influenced by related 
to cultural attitudes. Culture barriers among certain minority cancer patients include 
fatalism, medical mistrust and lack of the health care providers and individuals who have 
suffered from medical discrimination (Yanez et al., 2012). 
Mead et al (2013) conducted a systematic review of studies for shared decision- 
making and concluded that a shared decision approach to cancer care should extend 
beyond the general patient-provider to import key individuals and community members 
in the cancer treatment decision-making process. A conceptual model to access decision 




multiple determinants of cancer treatment (Figure 5) that include levels of influence for 
the patient, family, community, and provider (Mead et al., 2013). Researchers argue that 
the SMD approach is not necessarily appropriate for every cancer patient (Mead et al., 
2013). Addressing culture and personal preferences for treating cancer through effective 
patient center communication may improve adherence to treatment, may reduce the 
delays of cancer care for racial ethnic minorities (Mead, et al., 2013).   
 
Figure 5. A conceptual model cancer treatment decision-making racial ethnic minority  
patients. Source: Adopted from Mead et al., 2013. 
 
Cancer cases are expected to increase as the U.S. population ages and leads as a 
cause of death. As an example, for older women with breast cancer will affect many older 
women and increase among racial and ethnic minority women (CDC, 2014). Multiple 
health disparities exist for breast cancer treatment among older minority women; 
socioeconomic status, poor treatment decision-making outcomes, access to health 




populations (Luo et al., 2015). African American and Latina women receive poorer 
patient-physician communication and are less likely to receive aggressive breast cancer 
treatment like breast-conserving surgery, and radiation treatment as compared to whites 
(Yanez, Stanton, & Maly, 2012). Understanding more about cancer treatment decision 
making for aging minority populations can improve cancer disparities and health equity 
among vulnerable populations.  
Summary  
This chapter has presented the Baby Boomer population is living longer than any 
birth cohort in United States history, so it poses new challenges not seen in before 
modern healthcare. The health disparities in this cohort, born between 1946 and 1964 are 
well known. Moreover, the cancer rates expected to rise as this population ages and 
become more diverse. Having a good patient-provider communication system is essential 
to lowering cancer health disparities among the study population that makes decisions 
about cancer treatment. Cultural and ethnic factors, treatment delays due to in effective 
communication, workforce shortages, distrust of providers and healthcare system factors, 
the rising cost of cancer all contribute to cancer health disparities and quality cancer care 





Chapter 3: Methodology 
Introduction  
The purpose of this study was to understand the personal experiences of aging 
minorities during cancer treatment decision making when communicating with their 
cancer care providers. The preceding section focused on the current literature related to 
Baby Boomer ethnic minorities’ decision making for cancer care treatment. The age 
cohort for this study was individuals between 50 and 74 years of age. Cancer health 
disparities in this cohort include an awareness of patient-provider communication and the 
quality of cancer treatment decision-making this communication facilitates. In this 
chapter, I outline a phenomenological research paradigm for this study along with the 
specific aims of the study, the setting, and the sample used to examine the lived 
experiences of participants. Additionally, in this section I discuss the participant selection 
process (inclusion and exclusion criteria), the role of the primary investigator, measures 
taken to protect all study participants, and data collection and data analysis procedures.  
Research Plan and Design 
I selected a phenomenological research method. Phenomenology studies focus on 
lived experiences or events in people’s lives and provides a framework for evaluating 
perception in a way that can further aid in understanding participants’ perspectives. The 
core attributes of phenomenology make it a good choice for qualitative inquiry as it 
allows for insight into the possible influences of perceptions on behaviors and actions 
(Creswell, 2009). A phenomenological researcher is concerned describing a person’s 




The interview was the data collection tool that I used to explore experiences of 
participants as a basis for this qualitative study. According to Giorgi (2008), questions for 
qualitative interviews should be broad and open-ended, allowing the participants 
opportunities to share their points of view. Active listening on the part of the researcher 
and probing for clarity are essential to getting participants to describe their experiences 
(Bevan, 2014).  
The central phenomena studied were experiences of minorities born between 1946 
and 1964 when making decisions concerning cancer treatment. I sought to understand the 
disparities in cancer diagnosis and treatment among this population group, especially as it 
related to the influence of patient-provider communication on treatment decisions for 
underserved racial and ethnic minorities diagnosed and treated for various types of 
cancers. Understanding specific healthcare-related factors in cancer treatment decisions 
may help determine interventions for the study population. The qualitative approach 
supported exploration and probing of study participant experiences, and the 
phenomenological research design resulted in obtaining good descriptive information 
(see Creswell, 2009). 
Research Questions 
The research questions guided the in-depth interviews, which were the primary 
collection tool to identify cancer treatment decision-making based on patient-provider 




Research Question 1: Do inadequate time allowed for medical decision-making 
and lack of active listening and empathy by care providers prove to be barriers to 
patient-provider communication for Baby Boomer minorities? 
Research Question 2: What are facilitators for post-cancer treatment (e.g., access 
to quality care and supportive networks) that improve quality of life of Baby 
Boomer minority cancer survivors? What are the barriers to improved quality of 
life?  
I used open-ended questions to gather data that provided insight about the 
experiences of the research subjects (see Penner & McClement, 2008; see Speziale & 
Carpenter, 2007). Campbell (2016) suggested that open-ended questions must have a raw 
theme to urge participants to describe how the phenomenon had influenced their lives and 
how the experiences uniquely affected them. In this study, in-depth interviews were the 
primary collection tool to answer the research questions.  
Descriptive variables such as race and ethnicity, educational attainment, age, sex, 
marital status, and insurance coverage information collected to inform the study. I asked 
specific questions about participants’ experience with cancer treatment decision making. 
For example, one question was, “I like to you to share your cancer treatment decision-
making experiences in the past 2 years.” (Arora, et al., 2011; see Palmer, 2014; see 
Sheppard, et al., 2010). These interview questions measured patient-provider 
communication and cancer treatment decision making from follow up care experiences as 
perceived by the study participants. I used probes to solicit more details or to clarify 




interview questions to uncover participant perceptions of cancer treatment decision 
making and provider communication:  
1. Describe how you first learned about your cancer diagnosis.  
2. Did your cancer doctor discuss treatment options you could understand for 
making decisions about your cancer treatment process? If so, what did the 
doctor discus?   
3. How long after the cancer, diagnosis was your cancer treatment decision 
made.  
4. Did your cancer doctor encouraged your involvement to ask important 
questions about your cancer treatment options? If so, how? 
5. Did your doctor encourage you to voice your opinion (agree or disagree) 
about your cancer treatment or specific treatment recommendations?  
6. Please describe how family members or significant individual(s) influenced 
your cancer treatment decision.  
7. In what ways did family members or significant individual(s) communicate 
with your doctor about your cancer treatment options?  
8. In what ways do you feel your age played a role in your cancer treatment 
decision making? 
9. In what ways do you feel your financial resources played a role in your cancer 




10. Did your spiritual or religious beliefs influence your cancer treatment 
decisions? If so, please if it helped or hindered you dealing with this serious 
physical illness?  
11. In looking back, what things do you think the medical care team could do to 
improve quality cancer care with patients? 
12. Are there any additional comments you would like to provide about your 
cancer treatment decision experiences?  
These interview questions modified using the APECC population-based survey 
developed by researchers at the NCI (2011). The APECC survey was designed to 
measure perceived quality of cancer care follow-up from the cancer survivors’ 
experiences, assess the satisfaction of care within 12 months, and to understand cancer 
patients’ participation in their decision making for cancer treatment and follow up cancer 
care (NCI, 2011). Researchers assessed key factors critical to patient-provider 
communication necessary to promote quality of care after treatment for cancer survivors 
(Arora et al., 2011; Palmer, 2014). For example, areas of follow-up care experiences 
assessed were: (a) access to care, (b) physicians’ communication, (c) medical care team 
communication, (d) health promotion, and (e) coordination of care. Some questions used 
in the survey that informed physician communication ratings included: “In the past two 
years, how often did your cancer-related follow-up care physician(s):  
(a) Listen carefully to you,  
(b) Explain things in a way you could understand,  




(d) Encourage you to ask all the cancer-related questions you had, and  
(h) Involve you in decisions about your medical care as much as possible. 
This tool allowed me to gain a deeper and richer understanding of cancer survivors’ 
experiences of this aging population-based study with members of racial and ethnicities 
minorities in order to understand the barriers and facilitators for increasing quality cancer 
care.  
Role of the Researcher 
My role in this study I gathered and analyzed the data from the participants by 
conducting personal interviews. I narrowed the research problem down to the gaps in the 
literature. As a public health professional, I understand the challenges of aging and the 
growing cancer concerns of Baby Boomers as they age. To mitigate potential researcher 
bias I was open to and flexible in meeting the needs of the participants. I did not 
encourage participants to share information they were not ready to share or make them 
discuss topics that were not relevant to the specific research. 
Participant, Recruitment Strategy, Sample, Size 
Understanding racial ethnic differences for cancer treatment and decision-making 
is imperative to reducing health disparities among aging minority patients. Qualitative 
methodology is well suited for a phenomenological study for which previous research is 
limited on the experiences of aging minority populations when discussing cancer 
treatment options with their physicians. Potential participants eligible for recruitment will 
be individuals between the ages of 54-72. Study participants are diagnosed with a cancer 




higher, and are experiencing cancer treatment in the past 24 months from no surgery, 
chemotherapy, radiation therapy, or surgery. Study participants were English speaking 
and are mentally competent. Study participants can be male or female.  
The study size population will be up to 15 individuals born between 1946 and 
1964 who are cancer survivors and for purposes of this study are sufficient sample size to 
answer the research questions. In a similar study, Obikunle (2016) examined the personal 
experiences of 14 African American women, 40 years and older, perceived barriers to 
breast cancer screening. A sampling strategy, I selected for this qualitative study is 
random sampling technique that allows the researcher to use semi-structured interviews 
for the described research design. The specific criteria for the study that individuals are 
members of various ethnic and racial minority groups to facilitate the information 
necessary for response to the interview questions. This study, conducted in the 
metropolitan area of Atlanta, Georgia at a Community Health Center (CHC) that serves 
primarily low socioeconomic status cancer survivors. Previous studies show that 
underserved minority populations exhibit a higher disease burden as compared to whites; 
they often have late stage diagnosis and poor survival outcomes for cancer (Byrd et al., 
2011; Thompson et al., 2013). Baby Boomer minorities also receive fewer cancer 
treatment services compared to whites (NCI, 2016). The first eligibility criterion to 
participate in the study is to be an individual who self-identifies as one of the following 
racial or ethnic backgrounds: African American, Asian, Hispanic or Latino, American 
Indian/Alaska Native. Participants must also self-identify as a cancer survivors. 




the CHC as their access to oncology care. Qualitative methodology is well suited for a 
phenomenological study for which previous research is limited on the experiences of 
aging minority populations when discussing cancer treatment option with their 
physicians.  
As a sampling strategy, I selected for this qualitative study is semi-structured 
interviews for the described research design. The specific criteria for the study that 
individuals are members of various ethnic and racial groups to facilitate the information 
necessary for response to the research questions.  
Study participants recruited from the follow up care conducted at a Federally 
Qualified Health Center (FQHC) or Community Health Center (CHC) that serves 
primarily low socioeconomic status minority populations in a metropolitan area of 
Atlanta, Georgia. Previous studies show that underserved minority populations many 
times exhibit a higher disease burden as compared to whites; they often have late stage 
diagnosis and poor survival outcomes for cancer (Byrd et al., 2011; Thompson et al., 
2013). Baby Boomer minorities also receive fewer cancer treatment services compared to 
whites (NCI, 2016).  
Participant selection was from a range of racial and ethnic aging minorities that 
consisted of African Americans, Hispanic or Latina, Asian/Pacific Islanders, American 
Indian/Alaska Native. All participants included, informed of the purpose of the study, 





A goal for the sample size was 15 participants for this study. After obtaining 
demographic data from the participants, semi-structured face-to-face interviews 
conducted at a CHC setting to allow participants to articulate their cancer treatment 
experience, decision making, and patient-provider communication. The participants had 
the opportunity to share additional information about their cancer care experiences and 
follow up from the researcher if necessary.  
Data Collection 
The study intended to analyze data regarding the phenomena, context, and themes 
through direct observation and interaction experienced by minorities born between 1946 
and 1964 and their experience in receiving cancer care. After the Walden University’s 
Institutional Review Board (IRB) approval, I collected data in Atlanta, Georgia. The IRB 
is a formal committee established for responsible, ethical review and oversight of studies 
according to the U.S. Department of Health and Human Services Office for Human 
Research Protection, Regulations 45 CFR Part 46 (2018).  
Participants were asked open-ended questions to explore their experiences with 
patient-provider cancer treatment and care. All of the interviews were conducted in 
Atlanta, Georgia. The researcher worked closely with the CHC to identify eligible cancer 
participants to send an invitation letter describing the study. The researcher contacted 
study participants. Participants who agreed to the interview completed the informed 
consent for research. Interviews were recorded and transcribed into a Microsoft Word 
document and identify common themes for the research study. Names were not be 




identification of each study participant. The sample size was small, limited to 15 
participants to maximize the saturation of data. 
For confidentiality, interviews were face-to-face. The investigator probed 
participants’ cancer treatment experiences. Each interview lasted no more than 60 
minutes. An interview instrument by the researcher ensured each participant answers all 
the same general questions to solicit their individual experiences about cancer treatment 
and communication with their provider. Interviews were in a comfortable environment 
conducive to capturing the essence of their experiences while maintaining accuracy, 
privacy, and confidentiality of the data. The participant had the opportunity to provide 
feedback to add to richness to the data collected. 
Data Management and Analysis 
The analysis of all patient data collected through audio-recorded interviews by the 
researcher, and transcribed into a Microsoft Word document. Once transcribed, the 
researcher read the interviews while also listening to the recordings. Then the paper copy 
of the research material documents kept in a secure storage file. All interviews verified 
for accuracy, patient responses were analyzed using NVivo software for qualitative study 
data analysis. Specific data themes analyzed to examine Baby Boomer minorities’ cancer 
treatment experiences.  
Transcripts data analyzed from themes that pertained to Baby Boomers 
minorities’ cancer treatment experiences. The themes that emerge related to the barriers 




cancer treatment decision making. A stratified analysis by racial ethnic differences of 
patient-provider communication perceptions and cancer treatment decisions conducted. 
Reliability and Validity 
Specific steps to ensure reliability and validity in this study in the study. Validity 
in this qualitative research study determined the trustworthiness of the instrument to 
design to gather the data collection from participants. The face-to-face interviews were at 
the Community Participants’ conference room or study participant’s home. The face-to-
face interviews of participants’ data recorded for accuracy from the research findings. 
The data transcribed for reliability, and the transcripts read while simultaneously listening 
to the audio-recorded interviews. A final copy of the transcript provided to the 
participants to identify their experiences relative to the study and share feedback, if 
necessary.  
Summary 
Information in this chapter includes the research design, and specific 
methodology of the study. The researcher presented a rationale for each section.  
Furthermore, data collection, management, and analysis techniques identified. The 
selection of the participants, where the interviews took place and shared experiences was 
determined. Finally, this chapter supports the choice to use a qualitative approach to 
gather information from the study population. Semi structured interviews guided this 
qualitative study to gather patient experiences of cancer treatment for this research. 
Chapter 4 the results from the analysis and implications of findings for public health for 




Chapter 4: Results  
Introduction 
The purpose of this qualitative study was to examine health disparities among 
aging minorities during cancer treatment about decision making when communicating 
with their cancer care providers. In this chapter I describe the interview instrument, 
community partners, study setting, recruitment of participants, and data collection 
technique and analysis. I conducted in-depth face-to-face interviews with 10 cancer 
survivors during the months of January and April 2018. Individuals born between 1946 
and 1964 were eligible for the study. This chosen study cohort of interest was the aging 
Baby Boomer population who had experienced cancer. Participants must have been in 
cancer treatment for at least 2 years. 
Research Tool 
The data collection tool consisted of an interview guide (see Appendix B) I 
developed with twelve demographic questions and twelve open-ended questions for 
individuals who experienced any form of cancer. The first half of the interview guide 
consisted of basic demographic questions of age, education level, and type of cancer. The 
remaining section of the interview guide included interview questions that addressed two 
research questions:  
Research Question 1: Do inadequate time allowed for medical decision-making 
and lack of active listening and empathy by care providers prove to be barriers to 




Research Question 2: What are facilitators for post cancer treatment (e.g., access 
to quality care and supportive networks) that improve quality of life of Baby 
Boomer minority cancer survivors? What are the barriers to improved quality of 
life? 
Recruitment of Participants  
I recruited two community partners in North Georgia to locate participants to 
interview for the cancer study. After the IRB application approval, I sent an introduction 
letter and letter of cooperation (see Appendix A) requesting participation in the study to 
seven county area multipurpose resource centers in neighborhoods that serve a diversity 
of aging ethnic minorities explaining the purpose of the study to directly observe cancer 
treatment decision-making experiences among minorities. I received two signed letters of 
cooperation from organizations willing to participate in the study. The community 
organizations that were unwilling to participate in the study declined to provide signed 
letters. Prior to the interviews at the community organization partners, I contacted the 
directors of the organizations to set up a time to place a copy of the recruitment flyer 
seeking eligible study participants willing to talk about cancer care experiences with their 
care provider.  
Setting 
This study conducted in two counties of the Atlanta, Georgia area with a diverse 
population that include older minorities. Cancer is the second leading cause of death in 
Georgia; 45,000 individuals diagnosed with cancer and 15,500 die annually from this 




2016). Some cancer deaths in Georgia are preventable by detecting cancer early when 
treatment is most effective. Racial disparities in breast, cervical, prostate, colorectal, 
lung, and kidney cancers are apparent, with African American women and men in 
Georgia having higher age-adjusted incidence and mortality rates than Whites 
(McNamara et al., 2016). 
Community Partner Organizations 
For this study, Community Partner Organization A and Community Partner 
Organization B both agreed to be included in the study. Both these organizations are 
multiple-purpose centers that offer services for communities, specifically seniors over 55 
years of age. They also provide information, referrals, and professionals to facilitate 
better quality of life for senior citizens in these counties. Community Partner 
Organization A is a multi-purpose senior center that offers programs for active seniors 
that promote mental, physical, and emotional well-being. Community Partner 
Organization B is a multiple-service organization servicing community members with 
such services as family health education including offering a cancer support group. To be 
eligible for the cancer study, prospective participants needed to: (a) be male or female; 
(b) born between 1946 and 1964; (c) speak English and identify as Asian American, 
African American, Native American, or Hispanic/Latino; and (d) diagnosed with any 








I received approval from Walden University IRB (approval number 10-11-17-
0147607) prior to visiting the respective community partner organizations to collect data. 
I contacted the directors of the community partner organizations to schedule a time to 
visit to speak with them about my specific research agenda and address any questions or 
concerns they may have. Both Community Partner Organization A and B directors agreed 
the best time to visit and post recruitment flyers were during the busiest hours when 
many participants would gather for activities. I placed recruitment flyers where most 
prospective participants gathered with the goal of meeting those who met the criteria and 
where ready to participate.  
To facilitate the recruitment of potential participants, an information-sharing 
seminar with other volunteer service organizations such as AARP (American Association 
of Retired People) and VISTA (Volunteers in Service to America) during lunch hour was 
a good opportunity to meet members of Community Partner Organization A and share 
information about the cancer study. I also spoke with the cancer support group of 
Community Partner Organization B to share information about the importance of cancer 
screening and that as a person ages they are most at risk for developing many types of 
cancers. I was able to schedule interviews with prospective study participants to set a 
time convenient for them for interviews. During the initial visit, I explained the purpose 
of the study with each participant, reviewed the informed consent document with them, 




Sample Selection of Participants 
For this qualitative study, I used purposeful sampling techniques to identify the 
cancer study participants. The eligible participants included men and women from the 
Baby Boom cohort, defined as those individuals born between 1946 and 1964. After each 
interview, study participants were given a $25 gift card for their time and participation. 
Additionally, I advised participants that their names or other identifying information kept 
confidential. Participants understood that a pseudonym would identify their research 
participation in the study to maintain confidentiality. The participants who agreed to 
move further in the study process (N = 10) read, understood, and the signed consent 
forms. The study participants retained a copy of the consent form.  
I conducted interviews during weekdays when participants visited Community 
Partner Organizations A and B. The interviews were face-to-face, in-depth, and open-
ended. An interview guide provided the data for consistency among study participants 
(see Appendix B). The required sample size to understand the personal experiences of 
aging minorities regarding cancer treatment decision making when communicating with 
their care providers was 10 participants. All interviews were audio recorded with 
permission of the participant. The interviews lasted 45 minutes to 1 hour. During each 
interview, I would probe and asked additional questions to gather rich data from the 
participants while capturing the participants’ reactions during the reflective writing.  
Demographics  
The interview guide included twelve demographic questions. The sample included 




a mean age of 64.3 years. There were seven females and three males. The participants 
were African Americans (n = 7), Hispanics (n = 2), and Asian (n = 1). Some of the study 
participants reported to be married (n = 4). Only three participants were still working full-
time jobs and seven were retired. The level of education of the study participants ranged 
from high school graduates (n = 3) to graduate degrees (n = 4). The participants reported 
an annual income range of under $25,000 to over $100,000. The health insurance status 
of participants varied, with Tricare/VA (n = 1), Medicare (n = 4), Medicaid (n = 2), 
private employer insurance (n = 4) with one individual reporting having dual coverage. 
One individual also reported not having insurance during the interview after a lapse in 
Medicaid coverage. Table 3 highlights the demographic information collected during the 
in-depth interviews.  
Data Analysis 
For this study, I used the qualitative software NVivo 11 for Windows designed by 
QSR International. I reviewed all the transcriptions several times to identify common 
themes in relation to my two research questions. I used subcategories to describe the 
participants’ verbal responses to the cancer treatment experience. As proposed with the 
van Kaam method (Moustakas, 1994), I used the full descriptive analysis regarding the 
lived experiences to generate the main themes. The NVivo 11 for Windows software 
allows the researcher to code, sort, and analyze data summaries from each transcript. The 
NVivo software offers useful tools to prepare the analysis, work with the interviews, and 




I saved the audio recordings and transcripts and uploaded them to NVivo 11 
software for qualitative research to maintain data management and storage. According to 
Woods, Paulus, Atkins, & Macklin (2016), qualitative data analysis software such as 
NVivo is capable of allowing the researcher to synthesize multiple processes ensuring 
adequate data management and analysis techniques are in place to complete the research 
project. The NVivo software assisted in reducing manual processing time and allowed me 





Demographic Characteristics of Cancer Survivors  
Participant Characteristics                                                               Frequency     
 
Age (Born 1946-1964) 
   50-59 
   60-69 








    Male 







    African American 
    Hispanic 







   Below $25,000 
   $25,000-$35,000  
   $35,000-$50,000  
   $50,000-$75,000        










    Married 
    Divorced 
    Single 








     Less than high school  
     High school/GED   
     Some college 








Health Insurance Status 
     Tricare/CHAMPVA   
     Indian Health Service  
     Medicare         
     Medicaid            
     Private / Employer       
     Self-Pay                      
     No Insurance                                                     











    
*Dual health  
coverage 





Participants reported seven different cancer types: breast cancer (n = 7), colorectal 
(n = 1), prostate (n = 1), lung (n = 1), and kidney (n = 2) cancer. Two participants 
reported a dual cancer diagnosis and shared a painful discussion about having concurrent 
cancer treatments. All 10 women and men reported less than 6 months to commence their 
cancer treatment decision. All participants received conventional cancer treatment 
including surgery, chemotherapy, and or radiation; only one participant received hormone 
therapy as an alternative treatment. The cancer characteristics of study participants are 





Cancer Participant Summary   
Characteristics                                                                     Frequency     
 
Cancer Type 
       
      Breast             
      Prostate              
      Colon/rectal         
      Cervical/Ovarian  
      Leukemia        
      Lung               












Time making Cancer Treatment Decision 
       <6 months 





Cancer Treatment Decisions 
               Conventional Treatment  
       Surgery    
       Chemotherapy   
       Radiation   
      
               Adjuvant/Alternative  Treatment        
       Hormone therapy  
       Immune therapy 
       Targeted therapy 

















Table 5 provides a summary of cancer characteristics for each participant. The 
participant’s names were changed to protect their confidentiality. The table describes 
their cancer type, stage of cancer at diagnosis, specific cancer treatment, and length of 

























2 Amy Breast Stage III Surgery 5 years 
 



















7 Mateo Lung Stage I Surgery 
 
2 years 



















The data analysis from the in-depth interviews revealed nine major themes that 
emerged: (a) Cancer diagnosis, (b) Understanding and response, (c) Provider information 
giving, (d) Engaged patients, (e) Influence of social networks, (f) Cancer knowledge, (g) 
Financial burden, (h) Spirituality, and (i) Quality of cancer care. These themes 
highlighted the complex nature of patient-provider communication when discussing 
treatment decision making for older minority Baby Boomers.  
Research Questions 
The two research questions answered by the data collected from interviews and 
listed in this section. All participants were asked thinking back when they were diagnosed 
with cancer and communication they received from the doctor regarding cancer treatment 
decision making.  
Research Question 1  
To identify what participants perceived as cancer treatment decision making, the 
first research question asked if inadequate time allowed for medical decision-making and 
lack of active listening and empathy by care providers proved to be barriers to patient-
provider communication for minority Baby Boomers. From the first research question, 
four themes emerged.  
Theme 1  
Cancer diagnosis. This theme highlighted the importance of participants are 




the disease in early stages. Study participants shared how they first learned of their cancer 
diagnosis:  
Helen: I went for my annual mammogram check-up. I have had annual 
mammograms for the past 30 years. I was called back for another test because 
there was a spot on the breast x-ray. A biopsy was done and confirmed I had the 
breast cancer. I was so shocked!  
Amy: I had a routine mammogram. The doctor took tissue from breast, did the 
biopsy, and said it was malignant breast cancer. I was scared and shocked I would 
get the cancer. That was my third time having mammograms since my late forties.  
Kim: My husband felt the lump under my breast. It was painful. I was also in an 
auto accident and the ER doctors saw the spot in my chest area. Further testing 
from the mammogram, MRI, ultrasound, a biopsy, a PET scan, confirmed breast 
cancer.  
Beverly: I did a breast self-examination and felt a large lump in my left breast. 
The doctors say it was breast cancer Stage III. I had one breast removed with the 
chemotherapy. A year later, found out I had the cancer in my kidney.  
Jawanda: I felt a lump in my breast self-exam and then I went to the doctor. I got 
the mammogram. I had a lump in both breast. One side was much larger than the 
other was. It was surgery on one breast.  
John: I actually had cancer three times. The first was kidney cancer disease. I had 
prostate cancer twice. I first found out about the cancer when I went to the doctor 




from the diarrhea. So, doctor checked for MRI, found spot in one of the kidneys. 
Dr. said, it was kidney cancer and treated 3-5 years. The cancer came back and I 
went in for treatment for the prostate. The third time or this most recent cancer 
was the follow up the prostate exam where the PSA check had extremely 
elevated.  
Sofia: I moved from another country a couple years ago. After my husband got 
insurance I went to the doctor because my nipple was turning pinkish. Doctor did 
the mammogram, a biopsy, MRI and confirmed me positive for the breast cancer.  
Faye: I found out during my annual mammogram. I had large breast with cystic 
fibrosis. All testing confirmed breast cancer Stage IV. 
Theme 2 
Understanding and response. In this theme, study participants revealed their 
perception of comfort level in understanding the provider communication and making 
decisions about cancer treatment:  
Helen: I did not understand at first. The doctor said I have Stage II breast cancer. 
The primary doctor gave me a list of cancer doctors to choose. I researched and 
found a particular female doctor where she explained to me the mastectomy vs the 
lumpectomy procedures. I felt comfortable with her and chose to have the 
lumpectomy procedure. The doctor did not rush me into making the decision.  
Amy: To me the cancer surgery doctor did not discuss very much. I did not 




lumpectomy with chemo and radiation and remove my left breast. Later, I chose 
to have the breast completely removed.  
Kim: The cancer doctor did not discuss much and did not give me many options 
other than surgery with aggressive chemotherapy. I was somewhat able to 
understand and feel comfortable with the cancer treatment decision.  
Sofia: The doctor did not discuss. In addition, I did not know what to ask the 
cancer doctor. I just trusted everything the doctor said. He was Hispanic and 
spoke Spanish like me. It was easy for me to communicate with him easy to trust 
and to communicate. He never told me we have this option or that. I told him to 
do what we need.  
John: After three cancers, I learned after each cancer – doctor say I have cancer. 
Then what is the best treatment option? I will locate the best doctors. The doctors 
were competent.  
Mateo: No. Well, the doctor just explained I need surgery in a hurry.  
Jawanda: No. The doctor communicate he was 99/100% sure that everything is 
ok. I did not feel comfortable. 
Faye: A biopsy confirmed the diagnosis to determine the cancer. As a nurse, I 
understood procedures. However, after discussion, the doctor gave me an option 
of lumpectomy vs. mastectomy. I chose to undergo the lumpectomy.  
Participants responded to a follow-up questions regarding how long they waited 




and time preferences to moved forward with the cancer treatment recommendation after 
communicating with the doctor after the cancer diagnosis:  
Helen: I waited to after my two-week vacation and returned for breast cancer 
surgery. The doctor encouraged me not to put off longer having the procedure. I 
was ready to move on have it done.  
Beverly: Immediately. 
John: The decision was quick without hesitation. 
Amy: I waited a couple weeks and decided to have the breast removed. I wanted 
the cancer out of my body. 
Sofia: When doctor decided surgery and treatment I need, it was a month later 
before I decided. I told doctor I just wanted to have Thanksgiving with my family. 
The doctor described removing left my breast.  
Faye: It was an immediate decision at the time of notification of diagnosis and 
procedures. 
Kim: After the cancer doctor recommendation after the diagnosis, I waited a 
couple of weeks before deciding to have the surgery and aggressive 
chemotherapy. I had the chemotherapy, then surgery. However, the doctor found 
more cancer. 
Theme 3 
Provider information giving. This theme includes perceptions of participants 




about their cancer treatment option. Each participant expressed his or her perception of 
the cancer doctor:  
Amy: The doctor was not very encouraging to me. He told me we could do 
lumpectomy or mastectomy, A or B – that is it! The treatment decision based on 
the information given to me at the time.  
John: All doctors encouraged my participation. I was confident with the surgical 
doctor for the entire procedure. 
Jawanda: Yeah! All doctors on my cancer care team communicated with me 
individually and discussed everything and I had many questions to ask them.  
Kim: Not really. This doctor gave me some websites and other organizations to 
look on the computer about cancer, what I should expect. I was told; learn about it 
on my own time. He referred a monthly breast cancer support group. I did not 
participate. 
Sofia: Doctor no talk too much to ask me questions. It was so overwhelming. I did 
not know what to ask. He just say if I remove the breast and have the 
reconstruction. So another breast cancer survivor say no to breast reconstruction. I 
wanted to save my nipple. Doctor let me take control. I did not get another second 
opinion.  
Faye: Yes. The doctor was very good, said bring someone with me, and write 
down all my questions before coming to next visit. As a nurse, I did not always do 




information about breast cancer. In addition, the woman at the American Cancer 
Society provide me some useful information. 
Theme 4 
Engaged patients. This theme relates to if the doctor encouraged aging minority 
Baby Boomers to voice their opinion (agreed or disagreed) with the cancer decision test 
or specific treatment recommendation(s). Participants expressed their experiences during 
the shared decision-making process:  
Faye: After speaking with doctor, the decision was simple. She explained to me 
the difference between the lumpectomy and mastectomy. She said we‘d take the 
lump out or take the breast off. I said I did not see a need to remove my breast. I 
saw picture of cancer and bottom line the choice was mine. The doctor did not 
persuade me. 
Sofia: No. I did not question doctor recommendation. 
Amy: No. I thought having the cancer mean I was going to die. The doctor say no 
previous history in my family of breast cancer. 
 Beverly: No. 
Kim: No. This doctor did not explain much. I was alone. He was not a good 
doctor and I could not understand him much from his accent. He said I should 
read website information.  
Jawanda: Nope the doctor did not encourage me to speak, but something did not 
feel right in my spirit that the mammogram was good. I got a second opinion. 




Research Question 2 
Research question two explored facilitators for post cancer treatment, such as 
access to achieving quality cancer care and supportive networks that improve quality of 
life for Baby Boomer minority cancer survivors as well as barriers to such quality of life. 
Five themes emerged from in-depth interviews from the second research question. 
Theme 5 
Influence of Social Networks. This theme includes influence of family or 
significant persons on their cancer treatment decision. Study participants voiced the 
significance of having strong support systems:  
Helen: Strong support from sisters and children shared in the treatment decision 
and the surgery. It was important to deal with it and move on with or without 
family involvement. There was no need to put the surgery off any longer. 
Jawanda: My siblings and children were a strong support system. 
John: My beautiful wife was on significant in treating all my cancers. A good of 
friends and colleagues as well.  
Sofia: Yes. Although husband not very talkative. Family member encourage me 
to make my own decision. They did not try to talk me out of doing the breast 
reconstruction. 
Amy: No one encouraged me. I pretty much kept it quite to myself. I did share the 




Faye: No other family members or friends influenced my decision of breast 
surgery or cancer treatment decision. I think family members should be 
supportive of the cancer treatment decision. 
Participants also responded to a follow up question if a family member or significant 
person communicate with their doctor about their cancer treatment option:  
Helen: Daughter was there every step of the way, communicated with doctor, and 
shared information about my treatment to other family members. My daughter 
was there to ask questions and make notes for other family members. 
Kim: My husband was supportive and spoke with doctor in a way he could 
understand. My mother also spoke with doctors and they were supportive. 
Amy: My daughter spoke to doctor on my behalf and getting as much information 
to explain to me. It helped me understand the procedures of making the cancer 
decision. 
Sofia: My daughter talk to cancer doctor but she was in another state. The doctor 
was very quiet. Sometimes, I wish I asked more things. I just did not know what 
to expect. Someone gave book to read about breast cancer but I was afraid to read 
about the breast cancer. It is like, you want to know, but then you do not want to 
know.  






Cancer knowledge. This theme highlighted the participants’ perception of the 
incidence of cancer and risk factors for aging.  
Kim: No. I was shocked and felt I was much too young to have cancer. I know 
that I should receive cancer treatment or I die. I went with the doctors’ 
recommendation.  
Mateo: No. I was 65 when the cancer came. 
Amy: No. I was over 50 years old with a teenage son. I want live as long as I 
could. I never thought I would get cancer - maybe something else! 
Beverly: Nope. I had an emergency the cancer came so late. 
Helen: No. I did not think I would get the cancer at this age. However, the doctor 
said older women do better with chemo treatments than the younger women do. I 
have been relatively healthy and amazed I lived this long without having any type 
of surgery. 
John: Not really. My first type cancer I was 51 and with cancer again I am 62. 
Sofia: No. I did not think that at my 68 age I wanted to go through the breast 
cancer. If I were younger, I would not do it. It was too painful! It was hard. The 
women in the cancer support group had the breast reconstruction. Some were 
happy, but I learned every woman is different. 





Financial burden. This theme included the study participants financial resources 
affected their cancer treatment decision making such as their health insurance status, 
incurred any out of pocket costs as a barrier to pay for their cancer treatment and follow 
up care. Participants echoed concerns over cancer cost:  
Amy: I had health insurance, but it was not enough. It was not a good plan. I had a 
health savings. I had to pay for my mammogram from the health savings. The 
other x-rays were included in balance on hospital and doctor bill and making 
payment arrangements or $3000.00 or more for the out of pocket costs. I paid co-
pays for the follow up treatment visits. 
Beverly: I had little insurance and I was eligible for Medicaid treatment that 
covered the surgery so had $0 to pay out of pocket. 
Helen: I had Medicare and a Medicare Supplement insurance plan with high 
deductible option. My only payment has been for prescription drug co-pays. I did 
look at the bills for the procedures and saw the statements were over $5,000 per 
visit. It is expensive! I have had no other co-pays on x-rays, or chemo-treatment. I 
am blessed!  
John: I pay for two insurances Medicare and Tri-Care. It easy to pay for two 
insurance than have out of pocket treatment cost. Medicare is the primary 
insurance and Tricare is secondary. I was in an HMO with the first cancer. I had 
to choose the available doctors within the HMO pool so I could get the greatest 




sharing. The second cancer with Tri-care only with my total out of pocket was 
about $500. The third cancer and treatment, Medicare and Tri-Care both paid for 
the radiation treatment. Between these I am current out of pocket cost is $15 per 
treatment co-pay and transportation to the treatment center.  
Kim: My financial situation was important. I had no insurance. I received a 
positive diagnosis with breast cancer at health clinic that does free mammograms 
for women from the state. Medicaid funds paid for my breast cancer treatment. I 
paid no other out of pocket cost.  
Sofia: My husband had health insurance at the time of surgery, but we pay a lot 
out of pocket. In the beginning, there were so many tests for me. It was very 
expensive. Each time I visit the doctor, I would have to pay $250-300 dollars to 
prepay – cash or charge! I had lot of bills after the surgery, almost $2000 my 
husband put on the credit card and we tried to pay off the hospital as quick as 
possible.  
Faye: I had the insurance plan. I paid the 20% co-pay of the charges they sent me 
bills and I paid them. Later on, I had forgotten I had purchased a cancer 
supplement policy and it that paid me directly. I still have the cancer supplement 
plan just in case of a recurring cancer. 
Theme 8  
Spirituality. This theme included faith, beliefs in a higher power. Participants 
expressed their beliefs to ease hem through the cancer treatment process:  




Kim: Yes. I am a woman of God. I prayed for healing and asked why this 
happened to me. It is not cancer that kills; its treatment procedures that reduce the 
risk of dying. 
Helen: Through my strong faith, I have not suffered, amazing treatment process, 
and great doctors. I have faith in God and a good attitude helps! I had no reason to 
be sad about the cancer. God takes care of me. 
Jawanda: Yes, just simple prayer. 
John: Having faith, a strong supportive family. If you do not have a strong 
support group its difficult with not one or three cancers. Co-workers put me on a 
prayer list that went around the world. The prostate survivors group and great 
doctors.  
Sofia: Prayer was the only thing that kept me strong. I used to cry a lot. I no cry 
much now. I keep talking about it. It gets better after two years. The radiation 
make me so tired. The people at senior connections and Latin community support 
group were great. I do things now that bring me peace. 
Faye: I just prayed for healing through the entire procedure.  
Cho: I give thanks to Allah.  
Theme 9 
Quality of cancer care. This theme reflects on what the medical or cancer team 
and to improve quality of cancer. Participants identified their perception of quality of care 




Amy: I think my quality of cancer treatment was poor. I was supposed to have a 
person from American Cancer Society to visit for support group and counseling 
but they never followed up with me about where to get the prosthesis bra.  
John: My cancer care team was great supportive group. I felt the cancer team on 
the last two cancers were competent. I am better informed about cancer.  
Helen: My quality of cancer care was excellent. The cancer surgical staff and 
radiation clinic was on point. They told me to call any time. 
Kim: The cancer doctor was bad. I have had good doctors and bad doctors. The 
most important thing communication is good to discuss with a patient face to face 
and not give them a website you do not understand. I wish I had spoken with 
another cancer doctor to understand the process better. I did not have enough 
insurance in the beginning.  
Mateo: Excellent care team communicate all phases to understand. 
Sofia: I think I had great cancer care from the doctors and oncologist, and cancer 
team. It was good having the doctor speak Spanish and from my same country to 
make the journey easy for me. 
Faye: I think I got the best cancer treatment. It was good to have the primary care 
and oncologist doctors who really cared for me personally. Working as a nurse, I 
knew which doctors and hospital were the best to choose from around here. 
As a follow up question, study participants shared additional information regarding their 
cancer care treatment experiences:  




Cho: I never got the cancer screening years ago and now it is seem too late for 
me. 
Helen: My experience with diagnosis to the chemo treatments was good. I was on 
a new cancer treatment but my body rejected the initial treatment. I reduce the 
stress and worry. I am going on year 3 surviving the cancer.  
Jawanda: Some people do not like to talk about their cancer, but they should stay 
active if they can. 
Kim: The doctor gave me information to make the treatment decision. It was all 
up to me. I am thankful to have endured this process. I am feeling better and 
increasing my weight and my hair growing back. Looking at minorities for cancer 
is important.  
Sofia: I feel fortunate that the doctors found the cancer early enough when I came 
from my country time enough for cancer diagnosis to treat me. I was crying to 
doctors and they say not to cry because I am still alive. I am much better and 
happy now. It is a new day for me.  
Faye: I thought my cancer experience was a spiritual journey despite the chemo 
and radiation. It just made me a better person to help someone else on the journey.  
Mateo: Nothing else to say. 
Quality of Study 
In an effort for this study to be credible in areas of cancer health disparities 
among aging minorities is dependent upon quality of data and research findings. The goal 




myriad challenges present in a healthcare system is critical to understanding timely and 
accurate communications to have better inform decision making for effective cancer 
treatment. To ensure the study meets the essential criteria of trustworthiness in this 
qualitative research study was credible, confirmable, and dependable to gather the data 
collection from participants (Guba and Lincoln, 2007).  
1. Credibility – confidence in truth of findings using data triangulation using 
multiple data sources to increase and understanding of the study. The study 
participants were recruited from more than one community partner to share 
their various perspectives.  
2. Confirmability – ensure the transcripts from participants were verbatim of 
each respective interview. In addition, notes were taken during the interview 
process to gather richness of data collection. 
3. Dependability – this process was done while simultaneously listening to the 
audio-recorded interviews provided by the participants to identify their 
experiences relative to the study for feedback to review. 
Summary 
The purpose of the study was to understand the personal experiences of aging 
minorities during cancer treatment decision making when communicating with their 
cancer care providers in an urban area of North Georgia. Chapter 4 describes processes of 
collecting and analyzing data from the minority cancer survivors regarding their 




making. Purposeful sampling was done to study this phenomenon. Participant responses 
from in-depth interviews ask specific questions from the interview guide. 
The first research question explored the participants’ experience with cancer 
treatment decision making and patient-provider communication. The majority of the 
participants seemed satisfied with the patient-provider communication and access to 
cancer care treatment they received. However, a couple of participants felt provider 
communication was inadequate about their cancer treatment. The second research 
question looked at the importance of spiritual and social networks and barriers to access 
to quality cancer care. Many participants felt they received good quality of cancer care. 
Family, friends, and faith was significant to the participants. Chapter 5 will further 
address the interpretation of the cancer study findings, limitations of the study, and 
conclusions, social change implications, and researcher’s recommendations to increase 





Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this study was to examine the personal experiences of aging 
minorities during cancer treatment decision making when communicating with their 
cancer care providers. Multiple studies identified the significance of quality patient and 
provider communication between older individuals with cancer and their care provider. 
The literature is limited on studies that focus on specific experiences with cancer decision 
making and communication with providers for this population.  
I conducted a phenomenological research approach with in-depth face-to-face 
interviews among 10 individuals about their cancer experiences when communicating 
with their cancer care providers. Phenomenological research focuses on the participants’ 
worldview of experiences to understand a phenomenon under investigation (Creswell, 
1994). The investigator relies on the richness of descriptive in-depth interviews to 
understand their experiences, and then analyzes the data to generate common themes 
from the phenomenon.  
I identified the cancer treatment decision-making experiences of 10 individuals 
born between 1945 and 1964. In this chapter, I discuss an interpretation of the findings 
based on the research questions and themes related to cancer treatment decision-making 
as identified from participant data. I also provide the conceptual framework, limitations 





Interpretation of the Findings 
Study participants shared brief personal demographic information including age, 
gender, race, income; marital status, educational level, and health insurance status (see 
Table 3 in Chapter 4). Participants included a total of 10 women and men who were at 
least 2 years post diagnosis. The majority of the participants were retired. The average 
participant was 64.3 years of age. The number of cancer survivors age 65 and older is 
projected to rise in part due to aging population trends, changing demographics, and 
improvements in cancer care (Bluethmann, Mariotto, & Rowland, 2016; White, Hayes, & 
Richardson, 2015).  
Most participants reported having surgery and chemotherapy as primary 
treatments for their specific cancer type (see Table 6, Chapter 4). Many participants 
reported late stage of their cancers at diagnosis. Although this study did access late stage 
cancers, the current research indicates some late stages of cancer are highly associated 
with an increased risk of cancer death (Richardson, Tai, Rim, Joseph, Plescia, 2011; 
Henley et al., 2010). In addition, late stage cancers may be associated with fear, distress, 
and limited understanding of cancer treatment options (Schubart, Farnan, & Kass (2015). 
Screening cancer among specific demographic groups warrants early diagnosis of cancers 
(Wu, et al., 2015). Mobley and Kuo (2017) found that race or ethnicity for breast and 
colorectal cancer among African Americans, Hispanics, and Asians are more likely to 
receive late stage at diagnosis than Whites in most states are. 
Cancer survivors comprise multiple racial ethnic backgrounds with various cancer 




cancer is the most common cancer in women and CRC is the most common cancer in 
men (ACS, 2015, 2016). Despite progress in cancer care, disadvantaged populations are 
impacted by cancer health disparities, particularly racial and ethnic minorities, and the 
poor are disproportionately burdened by cancer (Smith & Hall, 2015; Zonderman et al., 
2014). Multiple studies indicate African Americans have the highest incidence of and 
death rates from cancer compared to other racial and ethnic minorities (NCI, 2018; ACS, 
2014; Maly, Umezawa, Ratliff, & Leak, 2011). According to Hummer & Gutin (2018), 
understanding the context of racial and ethnic health disparities, institutional and 
individual racism, lack of access to health care, and poor access to quality education and 
employment is necessary to interpret prevalence and mortality of all cancers among racial 
and ethnic minorities.  
Research Question 1 
RQ1: Do inadequate time allowed for medical decision-making and lack of active 
listening and empathy by care providers prove to be barriers to patient-provider 
communication for minority Baby Boomers? 
The interview questions revealed that interpersonal relationships could affect the 
outcome of quality of patient provider communication and influence cancer treatment 
decision making among Baby Boomers. Having good social support structures with a 
family member or friend as a facilitator is valuable for good cancer treatment decision 
making. The barriers to good decision-making identified in this current study were 
patient-provider miscommunication, needing more time with the doctor, and mistrust of 




want more communication that is informative to guide their decisions for cancer 
treatment after the cancer diagnosis. 
Theme 1: Cancer diagnosis. The study participants conveyed being 
overwhelmed with receiving the cancer diagnosis news after communicating with their 
providers during a follow up visit. The need for education of cancer prevention is critical 
for the older minority populations. All participants found out they were diagnosed with 
cancer during a follow-up examination the doctors’ recommendation of other diagnostic 
testing to confirm the cancer diagnosis. One participant reported been diagnosed for 
cancer three times. Although this study does not assess screening adherence, this is a 
critical finding that is consistent with the current literature that having a medical 
provider’s recommendation is a strong indicator of patients completing and getting 
screened for cancer for breast, cervical, prostate, and colorectal to find cancers early 
when they may be treatable or curable (CDC, 2018).  
Theme 2: Understanding and response. This theme identified barriers to 
empathy, time listening, understanding, and response of participants when facing a 
complex decision. The study participants (n= 7) perceived poor interpersonal 
communication as a lack of understanding cancer treatment decision making when 
discussing cancer treatment options with their providers, along with other unmet 
information needs. Communication of empathy, caring, respect, and imparting sensitivity 
to the patient’s health literacy is important for patients’ ability to understand health 
information for adequate treatment decision making for cancer (CDC, 2016). Good 




2016; Manfredi, Kaiser, Matthes, & Johnson; 2010). For example, participants did not 
understand chemotherapy versus radiation therapy or other effective treatment options for 
their type of cancer. This finding is consistent with the finding that shared 
communication, patient-centered care, and patient-provider communication is essential 
for all individuals with cancer and helps patients to receive bad news, deal with the 
emotional impact of cancer, understand complex information, and handle dealing with 
multiple health professionals (CDC, 2016; Song, Hamilton., & Moore, 2012; Epstein & 
Street, 2011). Limited health literacy contributes to health disparities and is a critical 
barrier to quality cancer communication and completion of doctors’ recommendations for 
routine screenings and treatment (NCI, 2018). 
Theme 3: Provider information giving. In the current study, three out 10 
participants indicated the providers did not encourage them to ask important questions 
about their treatment options. One participant, a nurse, was satisfied with her doctor’s 
suggestion to write down all her questions about the breast cancer surgery before the next 
appointment. According to Song et al. (2012), patients not knowing specific questions to 
ask the provider are limited in cancer treatment discussions, which translates into lack of 
communication. Sofia said, 
 The doctor did not discuss much. In addition, I did not know what to ask the 
cancer doctor. I just trusted everything the doctor said. He was Hispanic and 
speaks Spanish like me. It was easy for me to communicate with him, easy to trust 
and to communicate. He never told me we have this option or that. I told him to 




This finding is consistent with research by Heiney, Messias, Felder, Phelps, & Quinn 
(2017) that concluded women trusted their providers’ recommendation “just do it” and 
noted that trust may enhance adherence to breast cancer treatment. In contrast, findings 
from Ching-Li, Matthews, Dossaji, & Fullam (2017) examined patient-provider 
communication variables and concluded the majority of participants reported satisfaction 
with provider communication, were comfortable asking questions about their cancer 
diagnosis and treatment and with physicians discussing cancer diagnosis and treatment 
options with them.  
Theme 4: Engaged patients. All study participants were unaware they had a 
voice in deciding their cancer care. The majority of the participants (n = 9) did not seek 
another surgical opinion to validate the initial recommendation but followed the doctors’ 
recommendations. For example, one participant, stated, “The doctor communicate he was 
99/100% sure that everything is ok with me. I didn’t feel comfortable about the 
mammogram being good so I got a second opinion.” The second doctor confirmed 
through biopsy that cancer was present. This finding is consistent with patients talking 
openly regarding their concerns and fears with cancer treatment options (Epstein & 
Street, 2011). The lack of communication leads to medical mistrust in the health 
institutions, dishonesty about the diagnosis and treatment recommendation, and 
discrimination, which results in underutilization of health services (Song et al., 2012; 




Research Question 2 
What are facilitators for post-cancer treatment (e.g., access to quality care and 
supportive networks) that improve quality of life of Baby Boomer minority cancer 
survivors? What are the barriers to improved quality of life?  
Theme 5: Influence of social networks. All study participants indicated the 
strongest influence on their treatment decisions and follow up care was the loving support 
of family, friends, and higher power other than themselves. Family, friends, and or 
spiritual networks are essential for helping patients cope with cancer and promote healing 
during cancer treatment. This is consistent with findings from several studies that found 
social networks are effective to meet needs associated with improved survival of cancer 
(Yoo et al., 2010; Goodwin, 2007; Kroenke et al., 2006). Yoo et al. (2010) examined 47 
older African American, Asian, Caucasian, and Latino women from various ethnically 
diverse populations and concluded women with strong informal support from family and 
friends are more likely to have higher quality interactions with medical professionals. 
Supportive networks also include collaboration of community partnerships to address 
cancer disparities among racial ethnic minorities to increase health outcomes (Molina, 
McKell, & Mendoza, 2016; Ramandhan et al., 2012).   
Theme 6: Cancer knowledge. Participant perception was limited about cancer 
knowledge, risk factors, and increases of cancer, as a person gets older. This finding 
highlights the need for communicating cancer prevention, screening, detection, and 




350,000 individuals diagnosed with breast, cervical, or colorectal cancer, and nearly 
100,000 die yearly from these diseases (CDC, 2012).  
Theme 7: Financial burden. Accessing high quality cancer care depends on 
ensuring aging minority Baby Boomers receive timely access to cancer treatment. The 
study identified barriers such as health care systems factors, transportation, provider 
communication, cultural, or out-of-pocket cost may impacts access to cancer care. 
Participants (n=2) reported a health systems barriers with long wait-times at public or 
teaching health systems for follow up cancer care. All participants reported having health 
insurance coverage to access their cancer care treatment. The health insurance status 
reported by participants varied, with Tricare/Veterans Administration (n=1), Medicare 
(n=4), Medicaid (n=2), private employer insurance (n=4). Two participants had medical 
insurance but reported being under-insured for cancer treatment. These participants were 
still able to receive cancer treatment services through other public or community services 
with no out of pocket cost. Another participant had dual insurance coverage. Multiple 
studies indicate that having access to health insurance is the most important indicator in 
determining receipt of timely access to cancer treatment (Walker et al., 2014; Halpern, 
2008).  
For the current study, out of pocket, participants when facing cost of treatment for 
co-insurance, high deductibles and premiums, and medication incurred cost. This is 
consistent with the current study on two insured participants several months paying for 
out of pocket cost to cover coinsurance, deductibles, and prescription drugs. Amy 




or more for the out of pocket costs. I paid co-pays for the follow up treatment visits.” 
Three participants in the current study, over aged 65 insured under Medicare, indicated 
additional supplement plan coverage to helped pay for Medicare deductibles and 
coinsurance amounts reported substantially less out of pocket cost for cancer treatment. 
For example, Helen said, “I had Medicare and a Medicare Supplement insurance plan 
with the high deductible option. My only out-of-pocket payment has been prescription 
drug co-pays. I have not had other co-pays on x-rays, or chemo-treatment. I’m blessed!”  
The impact of financial difficulties on patients with cancer are becoming well 
recognized with financial distress can associated with physical, social, and emotional 
functioning reported (Delgado-Guay et al., 2015). Findings from a research study on the 
impact of health care costs on well-being and treatment among cancer patients, suggest 
that insured patients undergoing cancer treatment experience substantial financial burden, 
and that having health insurance coverage does not eliminate financial distress 
experienced by many cancer patients (Zafar et al., 2013).  
Income inequality and unemployment include disparities in access to health care 
and usually also associated with disproportionately lower cancer survival rates among 
many aging minorities (Abdelsattar et al., 2016). The Patient Protection and Affordable 
Care Act (ACA) extends Medicaid coverage to many cancer survivors who were unable 
to purchase affordable health insurance coverage in the individual Health Insurance 
Exchange Marketplace (ACA, 2010). The ACA expands access to care, largely through 
the Medicaid expansion, to individuals with 138% of those incomes near the national 




The Federal Government supports free or low cost breast and cervical cancer 
screening services across the United States to women who cannot afford cancer-screening 
services. This was important for helping Kim access cancer treatment care: “I had no 
insurance and was diagnosed with breast cancer at health clinic that does free 
mammograms for women from the state. Medicaid funds paid for my breast cancer 
treatment. I paid no other out-of-pocket cost.” Women diagnosed with cancer after 
receipt of breast or cervical cancer services through the National Breast Cervical Cancer 
Early Detection Program (NBCCEDP) are eligible for Medicaid coverage gain access to 
timely cancer treatment through the Breast and Cervical Cancer Prevention and 
Treatment Act of 2000, Public Law 106-354 (CDC, 2018). The law also extends 
coverage to American Indians and Alaska Natives who are eligible for health services 
provided by the Indian Health Service or by a tribal organization under the passage of the 
Native American Breast and Cervical Cancer Treatment Technical Amendment Act of 
2001 (CDC, 2018).  
Cancer costs are enormous. Estimates of the direct medical costs (total of all 
health care costs) for cancer in the United States in 2015 were $80.2 billion; with 52% for 
outpatient and physician office visits and 38% for inpatient hospital visits (ACS, 2018). In 
2018, about 609,640 Americans expected to die of cancer (ACS, 2016). These deaths 
include uninsured and ethnic minority groups diagnosed with cancer at a later stage, 
when treatment is more extensive, costlier, and less successful (ACS, 2018). The 
implementation of the Affordable Care Act (ACA) helps to alleviate some of the burden 




excluding coverage based on preexisting conditions, including cancer (ACA, 2010). 
Financial problems caused by cancer impact on quality of life (Fenn et al., 2014). It is 
important to provide people with information on cancer to understand their health 
coverage, seek financial assistance programs.  
Theme 8: Spirituality. For study participants, the relationship between family 
members, friends have a strong influence on cancer treatment decision making. All 
participants discussed prayer, faith, family, and giving all blessings to God for bringing 
them through the cancer experience. This finding is consistent with Sterba, Burris, 
Heiney, et al. (2014) on religiousness and spirituality are essential to survivorship, and 
care giving following primary cancer treatment and racial and ethnic minorities more 
likely to rely on religious and spiritual faith to cope with emotional support.  
Theme 9: Quality of Cancer Care. The majority of the study participants 
reported receiving good access and quality care in communication with provider about 
cancer treatment decision making. The participants verbalized that the importance of 
good interpersonal communication with provider as opposed a website or information 
pamphlet to learn about their cancer. Other participant factors include not knowing more 
about the insurance process, and getting a cancer screening years earlier when the cancer 
is detected and most treatable. These findings highlight the need for interventions aimed 
at insuring that patients and families are educated and empowered during the cancer care 
continuum. When patients are less empowered, during and after the cancer, treatment 
process can lead to poor health outcomes and reduce the quality of cancer care, and 




technology, underserved populations suffer from disparities in cancer treatment outcomes 
for rural populations, and the elderly. Patient decision making may be influenced by 
attitudes and beliefs about specific treatments, life circumstances and competing 
demands, health literacy, and perceptions about the health care system (Frey et al., 2016). 
When patients are less empowered, during and after the cancer treatment process can lead 
to poor health outcomes, reduce the quality of cancer care, and increased survival rates. 
These findings suggest that engaged patients is a central goal for individuals living with 
cancer during the shared decision-making process.  
Conceptual Framework 
The SEM was the framework to develop my research agenda, data analysis and 
summary. The findings from this study focused on timely access to cancer treatment 
services influenced by the intrapersonal, interpersonal, community, organizational, and 
public policy.  
The organizational level of SEM has a strong influence on patient-provider 
communication, cultural competency, and health literacy for cancer prevention for racial 
and ethnic minorities. For example, the organizational level of SEM is where individuals 
or patients have access to providers for cancer services. First, having a medical home for 
patients so that providers can communicate a recommendation or reminder for screening, 
and follow-up for patients’ access to cancer care. Stigma or fear of having received a 
diagnosis for cancer, financial burden, and or transportation to the treatment facility are 
access barriers. The organizational level of SEM also influences effective interventions to 




patients, individual providers and health systems, academia, faith based organizations, 
media, and state health departments at work to reduce burden of cancer and improve the 
quality of life for cancer survivors. The policy level also addresses improvements in the 
overall health of cancer survivors Healthy People 2020 and the Affordable Care Act 
(ACA) expands insurance reforms and improve access to cancer care with specific 
measures to eliminate barriers to reduce cancer health disparities among aging minorities. 
Limitations of the Study 
This study had some important limitations including the small sample size, 
geographic location, and potential for bias. The study was limited to a sample of 10 
participants. The limited sample size may not accurately represent the perception of 
patient-provider communication among aging minority patients when discussing cancer 
treatment. The study was limited to an urban area of North Georgia; therefore, the study 
findings may not reflect the experiences of racial and ethnic minority Baby Boomers 
outside the study area. Additionally, the study did not account for cancer treatment side 
effects, biology of cancer, palliative or hospice care communications or other chronic 
conditions that advance cancer. The study did not collect data from health care providers 
who are critical to achieving effective communication for aging minorities. The data was 
reported by study participants, therefore, there is a potential for recall bias. Another 
limitation is that only two community organization partners agreed to participate in the 
study that limited the ability to recruit a diverse sample of racial and ethnic minorities. 
The majority of the study participants were African American, an ethnic group that is 




have conveyed a unique perception of their cancer treatment decision-making 
experiences. This study may affect future outcomes research needs for aging racial and 
ethnic minorities. 
Recommendations 
This study looked at patient-provider communication to reduce cancer among 
aging racial and ethnic minority populations at high risk for cancer in the United States. 
The findings of this study contribute to the existing literature of minority Baby Boomers 
perception of patient and provider communication when making cancer treatment 
decisions. To reach this aging minority population health care providers should 
strengthen shared communication and decision-making strategies to improve quality and 
reduce cancer health disparities.  
Another recommendation is increase education among the growing aging 
populations about access barriers to health insurance to increase their understanding of 
cancer care and patient cost of cancer treatments. Engaging patients with cancer and their 
families with communities strengthens support networks and increases the quality of life 
for cancer survivors. The literature is scant on patient perception of cancer among aging 
minority populations in community settings. A specific recommendation is for the 
inclusion of older racial ethnic populations in research interventions to better understand 
and respond to the needs of this population when communicating with providers about 
cancer treatment decision-making. For example, some older cancer patients may distrust 
the healthcare system, or providers who deliver inadequate or inequitable communication 




with representatives of older individuals of color may make it more accessible to address 
communication gaps during the cancer treatment decision-making experience. Materials 
can be translated into various languages to convey culturally appropriate messaging to 
make it easier for patients and providers to understand the shared decision making. 
Finally, the recruitment of older minority participation into aging research studies needs 
to evaluate effective interventions for specific populations living with cancer.  
Implications for Social Change 
The findings from this study has the potential to affect social change for 
underserved men and women aging populations. The findings may contribute to body of 
knowledge about the lived experiences of racial and ethnic minorities regarding cancer 
interventions to improve patient-provider communications among aging Baby Boomers. 
In addition, the study may lead to future research to identify important factors to advance 
the field of cancer epidemiology. Additionally, the findings have the capability to inform 
public health approaches that correlate to poor health outcomes for cancer diagnosis and 
treatment relevance to minority aging and health disparities in the United States. The 
results of the study suggest a need to bring awareness to community-based organizations 
serving aging minorities and may reduce access barriers to cancer treatment when faced 
by cancer survivors. 
Summary 
In conclusion, based on data analysis from this qualitative, phenomenological 
study incorporated in-depth interviews with 10 cancer patients currently in treatment. 




professionals must be accountable to needs of the individuals during the transition from 
diagnosis to treatment decision making. The findings from this study may add to limited 
knowledge on cancer treatment decision making in aging racial ethnic minorities can 
improve cancer disparities and health equity among vulnerable populations.  
Research Question 1 explored the participants’ experience with cancer treatment 
decision making with patient-provider communication. It was determined, that 
communication is essential to trust between the patients and providers to help cancer 
patient understand complex information, cope with uncertainty and emotional impact of 
the cancer experience, and make appropriate and timely cancer treatment decisions. 
Significant findings identified barriers related to the provider’s miscommunication, 
needing more time with the cancer doctor, and mistrust of the medical professor. Poor 
interpersonal communication as a lack of understanding cancer treatment decision 
making when discussing cancer treatment options with their providers.  
Research Question 2 explored facilitators for post cancer treatment, the 
importance of spiritual and social networks and barriers accessing quality cancer care. All 
participants indicated the strongest influence on their cancer treatment decisions and 
follow up care was the loving support of family, friends, faith in God, and prayer. These 
are all essential for helping cancer survivors cope with cancer. Additionally, the financial 
burden for underinsured participants through out of pocket cost to cover coinsurance, 
deductibles, and prescription drugs for cancer treatment impacts quality of life. Reducing 
long wait-times at public or teaching health systems is a barrier when navigating follow 




Lastly, Chapter 5 discussed the conceptual framework of the study based on the 
Social Ecological Model (SEM) focused on multi-level approaches of patient-provider 
communication from a public health perspective. The recommendations and findings of 
this study may contribute to the existing literature of minority Baby Boomers perception 
of patient-provider communication when making cancer treatment decisions. To reach 
the aging minority population health care providers should strengthen access and improve 
communication strategies may reduce mortality and morbidity of certain cancers. 
Additionally, the results of the study may bring awareness to care givers and cancer 
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Appendix A: Letter of Cooperation 
Letter of Cooperation from (Insert Community Health Center Partner) 
 





Dear Patrice L. Kemp,  
 
Based on my review of your research proposal, I give permission for you to conduct the 
study entitled Cancer Treatment Decision Making in Aging Minorities within the 
(Community Health Center). As part of this study, I authorize you to conduct up to 15 
semi-structured in-depth interviews with individuals born between 1946 and 1964, 
diagnosed with a cancer such as breast, cervical, colorectal, prostate or other diagnosed 
form of cancer. Proper names will not be used and participants will be assigned a 
pseudonym to protect their identity. Interviews can last up to 1 hour. Individuals’ 
participation will be voluntary and at their own discretion. 
 
To ensure validity, Ms. Kemp may audio record the interview of consent form study 
participants. A structured interview note taking for consistency with study participants 
will follow all interviews. If requested, (Community Health Center) will receive an 
electronic copy of the study.  
 
We understand that our organization’s responsibilities include permission to interact with 
participants for completing this research. We reserve the right to withdraw from the study 
at any time if our circumstances change.  
 
I confirm that I am authorized to approve research in this setting and that this plan 
complies with the organization’s policies. 
 
I understand that the data collected will remain entirely confidential and may not be 
provided to anyone outside of the student’s supervising faculty/staff without permission 












Walden University policy on electronic signatures: An electronic signature is just as valid as 
a written signature as long as both parties have agreed to conduct the transaction 
electronically. The Uniform Electronic Transactions Act regulates electronic signatures. 
Electronic signatures are only valid when the signer is either (a) the sender of the email, or 
(b) copied on the email containing the signed document. Legally an "electronic signature" 
can be the person’s typed name, their email address, or any other identifying marker. Walden 
University staff verify any electronic signatures that do not originate from a password-





Appendix B: Interview Guide 
Personal Interview Guide 
 
Cancer Treatment Decision Making in Aging Minorities  
 
Code ID #: ___________     
Date: _______________   Place/Time of Interview: 
______________ 
Participant Sociodemographic 
1.  Age: ____ 
 
2.  Gender:   
     Male ____     Female ____  
 
3.  Race/Ethnicity:  
 Asian ___ Black or African American ___ Indian/Alaska Native___  
 Hispanic/Latino ___ Hawaiian or Pacific Islander ___White ___ Other __ 
 
4.  Marital Status:  
     Single ____ Divorced ____ Married____ Widowed ____ 
 
5.  Educational level: 
     Less than high school _____ 
     High school/GED  _____ 
     Some college  _____   
     College graduate _____ 
 
6.  Income: 
     Below   - $25,000 _____ 
     $25,000 - $35,000 _____ 
     $35,000 - $50,000 _____ 
     $50,000 - $75,000       _____ 





7.  Health insurance status: 
     Campus/Tricare/VA _____ 
     Indian Health Service _____ 
     Medicare              _____ 
     Medicaid             _____ 
     Private / Employer      _____ 
     Self-Pay                      _____ 
     Other                           _____ 
     No insurance               _____  
 
8.  Type of cancer: 
     Breast            _____ 
     Prostate            _____ 
     Colon/rectal        _____ 
     Cervical/Ovarian _____ 
     Leukemia   _____     
     Lung              _____ 
     Other     _____ 
 
9.  Stage of cancer at diagnosis: 
     Stage I   _____ 
     Stage II   _____ 
     Stage III or IV  _____ 
 
10. Type of Cancer treatment: 
      Surgery   _____ 
      Chemotherapy  _____ 
      Radiation   _____ 
      Hormone therapy _____ 
      Immune therapy  _____ 
 
11.  Length of time (years) with cancer treatment provider: 
        < 2   _____ 
        3-4   _____ 





12.  Other medical condition(s): 





1. Describe how you first learned about your cancer diagnosis?  
 
2. Describe how your cancer doctor discussed treatment options you 
can understand in making decisions about your cancer treatment 
process?    
 
 
3. Please tell me how long was your cancer treatment decision made 
after the cancer diagnosis?  
 
4. Please describe how your cancer doctor encouraged your 






5. Did your doctor encourage you to voice your opinion (agree or 
disagree) about your cancer decision test or specific treatment 
recommendation?  
 
6. Please describe how family members or significant individual(s) 
influenced your cancer treatment decision.   
 
 
7. What ways have the family member or significant individual(s) 
communicated with your doctor about your cancer treatment 
options?  
 
8. In what ways do you feel your age plays a role in your cancer 
treatment decision making? 
 
 
9. In what ways do you feel your financial resources play a role in 





10. Did your spiritual beliefs and religion engagement influence your 
cancer treatment decisions? If so, explain how you dealt with this 
serious physical illness?  
 
11. In looking back, what things do you think the medical care team 
can do to improve quality cancer care with patients? 
 
12. Are there any additional comments you would like to provide 






Thank you for participating in this interview. The confidentiality of all 
responses will be maintained. 
 
